STOCK TITAN

First Phosphate six-month loss widens to C$19.5M

NRCan approved up to C$16,717,722 in eligible feasibility-study reimbursements, alongside separate capped support for transmission and road work.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

First Phosphate Corp. reported unaudited results for the six months ended August 31, 2026, while advancing its Québec phosphate projects and downstream feasibility work. The company recorded a net loss of C$19.5 million, compared with C$3.8 million a year earlier, and used C$21.1 million in operating activities versus C$5.4 million. It has not generated revenue. Cash and cash equivalents were C$19.9 million and working capital was C$22.7 million at August 31, 2026.

Exploration and metallurgy spending was C$13,571,989, mainly related to drilling at Bégin-Lamarche. NRCan approved reimbursement of up to C$16,717,722 for eligible feasibility-study expenditures through March 31, 2028. Separate infrastructure agreements provide contributions of up to the lesser of 50% of eligible costs and C$3,071,587 for transmission work and C$1,771,350 for road work. Management said financing raised as of August 31, 2026 was sufficient to sustain operations for the next twelve months, while noting continued operations are contingent on obtaining additional financing. The Bégin-Lamarche feasibility study has a targeted completion date of calendar Q1 2027.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 2 points

How the balance works

Positive

  • None.

Negative

  • Moderate pointSix-month net loss increased to C$19.5 million from C$3.8 million.
  • Moderate pointOperating cash use increased to C$21.1 million from C$5.4 million.

Filing Explained

By August 31, 2026, common shares outstanding had risen to 190,419,664 from 177,199,011, reducing existing holders’ ownership percentages absent offsets.

This October 22 Form 6-K furnishes unaudited interim statements and MD&A, and records completed six-month equity financing: 8,849,145 shares issued and C$17,698,290 of proceeds from share and warrant issuances.

During the six months, NRCan reimbursement claims of C$2,034,893 were recorded and C$695,654 had been received; a further C$14,272,458 was not recognized as a receivable because collection was uncertain.

Ultion’s later plant-design and equipment phase, estimated at US$5.65 million plus optional services, and its US$1.5 million start-up phase remained unapproved and uncommitted as of August 31, 2026; no obligation for them was recognized.

Net loss C$19.5 million Six months ended August 31, 2026; C$3.8 million for the comparable 2025 period
Net cash used in operating activities C$21.1 million Six months ended August 31, 2026; C$5.4 million for the comparable 2025 period
Cash and cash equivalents C$19.9 million As of August 31, 2026
Working capital C$22.7 million As of August 31, 2026
Mining exploration and metallurgy expenditures C$13,571,989 Six months ended August 31, 2026
NRCan feasibility-study reimbursement Up to C$16,717,722 Eligible expenditures incurred January 9, 2026 through March 31, 2028
going concern financial
"prepared the condensed interim consolidated financial statements on a going concern basis"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
flow-through share premium liability financial
"increase in the flow-through share premium liability arising from flow-through financings"
Mineral Resource Estimate technical
"Updated Bégin-Lamarche MRE"
A mineral resource estimate is a calculated approximation of how much metal or mineral material likely exists in a particular deposit and where it sits underground, similar to estimating how many cookies are in a jar by peeking at the layers. It matters to investors because it provides a data-based starting point for judging a project's potential value, future production and risks, while not guaranteeing recoverable or profitable amounts.
preliminary economic assessment technical
"a preliminary economic assessment dated effective December 4, 2024"
A preliminary economic assessment is an initial analysis that estimates the potential profitability and feasibility of a project or resource, such as a new mineral deposit or development venture. It provides a rough idea of costs, benefits, and risks, helping investors decide whether to pursue more detailed studies. This early evaluation is important because it offers a snapshot of whether the project is worth further investment and development.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What was PHOS's net loss for the six months ended August 31, 2026?

First Phosphate reported a net loss of C$19.5 million for the six months ended August 31, 2026, compared with C$3.8 million for the six months ended August 31, 2025. The company also reported that it had not generated revenue.

How much operating cash did PHOS use in the six months ended August 31, 2026?

First Phosphate used C$21.1 million in operating activities during the six months ended August 31, 2026, compared with C$5.4 million during the six months ended August 31, 2025. Financing activities provided C$20.9 million in the current period.

What NRCan feasibility-study grant did PHOS disclose?

NRCan approved reimbursement of up to C$16,717,722 for eligible expenditures incurred between January 9, 2026 and March 31, 2028. First Phosphate recorded C$2,034,893 in claims under the grant during the six months ended August 31, 2026, of which C$695,654 had been received.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October, 2026                                   .

 

Commission File Number 001-43425                            

 

First Phosphate Corp.

(Translation of registrant’s name into English)

 

1055 West Georgia Street, 1500 Royal Centre, P.O. Box 11117, Vancouver, British Columbia, V6E 4N7

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

☐ Form 20-F           ☒ Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ___

 

 

 

 

SUBMITTED HEREWITH

 

The following documents of the Registrant are submitted herewith:

 

Exhibit Description
99.1 Interim Unaudited Financial Statements for the 3 month period ended August 31, 2024
99.2 Management Discussion and Analysis for the 6 month period ended August 31, 2024
99.3 Certification of Interim Filings - CEO
99.4 Certification of Interim Filings - CFO

 

2 of 3 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

First Phosphate Corp.
(Registrant)

 

Date: October 22, 2026 By /s/”Bennett Kurtz”
    (Signature)*

 

Bennett Kurtz, Chief Financial Officer
* Print the name and title under the signature of the signing officer.

 

3 of 3 

false Q2 2026 2026-08-31 --02-28 6-K First Phosphate Corp. 001-43425 0001490078 First Phosphate Corp. 891765 0001490078 2026-03-01 2026-08-31 0001490078 2026-08-31 0001490078 2026-02-28 0001490078 2026-06-01 2026-08-31 0001490078 2025-06-01 2025-08-31 0001490078 2025-03-01 2025-08-31 0001490078 PHOS:CommonShareMember 2025-02-28 0001490078 PHOS:ContributedSurplusMember 2025-02-28 0001490078 PHOS:SharesToBeIssuedMember 2025-02-28 0001490078 ifrs-full:RetainedEarningsMember 2025-02-28 0001490078 2025-02-28 0001490078 PHOS:CommonShareMember 2026-02-28 0001490078 PHOS:ContributedSurplusMember 2026-02-28 0001490078 PHOS:SharesToBeIssuedMember 2026-02-28 0001490078 ifrs-full:RetainedEarningsMember 2026-02-28 0001490078 PHOS:CommonShareMember 2025-03-01 2025-08-31 0001490078 PHOS:ContributedSurplusMember 2025-03-01 2025-08-31 0001490078 PHOS:SharesToBeIssuedMember 2025-03-01 2025-08-31 0001490078 ifrs-full:RetainedEarningsMember 2025-03-01 2025-08-31 0001490078 PHOS:CommonShareMember 2026-03-01 2026-08-31 0001490078 PHOS:ContributedSurplusMember 2026-03-01 2026-08-31 0001490078 PHOS:SharesToBeIssuedMember 2026-03-01 2026-08-31 0001490078 ifrs-full:RetainedEarningsMember 2026-03-01 2026-08-31 0001490078 PHOS:CommonShareMember 2025-08-31 0001490078 PHOS:ContributedSurplusMember 2025-08-31 0001490078 PHOS:SharesToBeIssuedMember 2025-08-31 0001490078 ifrs-full:RetainedEarningsMember 2025-08-31 0001490078 2025-08-31 0001490078 PHOS:CommonShareMember 2026-08-31 0001490078 PHOS:ContributedSurplusMember 2026-08-31 0001490078 PHOS:SharesToBeIssuedMember 2026-08-31 0001490078 ifrs-full:RetainedEarningsMember 2026-08-31 0001490078 ifrs-full:BottomOfRangeMember 2026-03-01 2026-08-31 0001490078 ifrs-full:TopOfRangeMember 2026-03-01 2026-08-31 0001490078 PHOS:BusinessDevelopmentMember 2026-03-01 2026-08-31 0001490078 PHOS:BusinessDevelopmentMember 2025-03-01 2026-02-28 0001490078 PHOS:MiningExplorationAndMetallurgyMember 2026-03-01 2026-08-31 0001490078 PHOS:MiningExplorationAndMetallurgyMember 2025-03-01 2026-02-28 0001490078 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2026-03-01 2026-08-31 0001490078 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2025-03-01 2026-02-28 0001490078 PHOS:RegulatoryAndComplianceExpensesMember 2026-03-01 2026-08-31 0001490078 PHOS:RegulatoryAndComplianceExpensesMember 2025-03-01 2026-02-28 0001490078 PHOS:ResearchAndDevelopmentMember 2026-03-01 2026-08-31 0001490078 PHOS:ResearchAndDevelopmentMember 2025-03-01 2026-02-28 0001490078 PHOS:ProfessionalFeesMember 2026-03-01 2026-08-31 0001490078 PHOS:ProfessionalFeesMember 2025-03-01 2026-02-28 0001490078 PHOS:LicensingOptionAreementMember PHOS:IntegralsPowerLimitedMember 2023-01-10 0001490078 2025-03-01 2026-02-28 0001490078 PHOS:LacalOrignalFlagshipAreaMember 2025-02-28 0001490078 PHOS:BeginLamarcheAreaOneMember 2025-02-28 0001490078 PHOS:BlueskyAreaMember 2025-02-28 0001490078 PHOS:LacalOrignalFlagshipAreaMember 2025-03-01 2025-08-31 0001490078 PHOS:BeginLamarcheAreaOneMember 2025-03-01 2025-08-31 0001490078 PHOS:BlueskyAreaMember 2025-03-01 2025-08-31 0001490078 PHOS:LacalOrignalFlagshipAreaMember 2025-08-31 0001490078 PHOS:BeginLamarcheAreaOneMember 2025-08-31 0001490078 PHOS:BlueskyAreaMember 2025-08-31 0001490078 PHOS:LacalOrignalFlagshipAreaMember 2026-02-28 0001490078 PHOS:BeginLamarcheAreaOneMember 2026-02-28 0001490078 PHOS:BlueskyAreaMember 2026-02-28 0001490078 PHOS:LacalOrignalFlagshipAreaMember 2026-03-01 2026-08-31 0001490078 PHOS:BeginLamarcheAreaOneMember 2026-03-01 2026-08-31 0001490078 PHOS:BlueskyAreaMember 2026-03-01 2026-08-31 0001490078 PHOS:LacalOrignalFlagshipAreaMember 2026-08-31 0001490078 PHOS:BeginLamarcheAreaOneMember 2026-08-31 0001490078 PHOS:BlueskyAreaMember 2026-08-31 0001490078 PHOS:BeginLamarcheAreaMember 2025-03-01 2025-08-31 0001490078 PHOS:BeginLamarcheAreaMember 2026-03-01 2026-08-31 0001490078 2025-09-23 0001490078 2026-01-01 2026-08-31 0001490078 2026-08-05 0001490078 2026-08-05 2026-08-05 0001490078 ifrs-full:SharePremiumMember 2026-02-28 0001490078 ifrs-full:SharePremiumMember 2025-02-28 0001490078 ifrs-full:SharePremiumMember 2026-03-01 2026-08-31 0001490078 ifrs-full:SharePremiumMember 2025-03-01 2026-02-28 0001490078 ifrs-full:SharePremiumMember 2026-08-31 0001490078 2024-12-16 2024-12-16 0001490078 2026-01-05 0001490078 2026-01-05 2026-01-05 0001490078 PHOS:BridgeLoansMember 2026-02-28 0001490078 PHOS:BridgeLoansMember 2025-02-28 0001490078 PHOS:BridgeLoansMember 2026-03-01 2026-08-31 0001490078 PHOS:BridgeLoansMember 2025-03-01 2026-02-28 0001490078 PHOS:BridgeLoansMember 2026-08-31 0001490078 2026-03-11 0001490078 2026-03-09 2026-03-11 0001490078 PHOS:ContributedSurplusMember 2026-03-09 2026-03-11 0001490078 2026-04-30 0001490078 2026-04-28 2026-04-30 0001490078 PHOS:ContributedSurplusMember 2026-04-28 2026-04-30 0001490078 2026-06-10 2026-06-12 0001490078 2026-07-08 2026-07-10 0001490078 ifrs-full:RestrictedShareUnitsMember 2026-07-10 0001490078 ifrs-full:RestrictedShareUnitsMember 2026-07-10 0001490078 ifrs-full:RestrictedShareUnitsMember 2026-07-08 2026-07-10 0001490078 2026-08-25 0001490078 2026-08-23 2026-08-25 0001490078 PHOS:ContributedSurplusMember 2026-08-23 2026-08-25 0001490078 ifrs-full:RestrictedShareUnitsMember 2026-08-31 0001490078 ifrs-full:RestrictedShareUnitsMember 2026-03-01 2026-08-31 0001490078 2025-05-29 2025-05-31 0001490078 2025-06-02 2025-06-02 0001490078 2025-07-29 2025-07-31 0001490078 2025-08-21 0001490078 2025-08-20 2025-08-22 0001490078 ifrs-full:RestrictedShareUnitsMember 2025-08-31 0001490078 ifrs-full:RestrictedShareUnitsMember 2025-08-29 2026-08-31 0001490078 2026-03-01 0001490078 PHOS:NonadjustingEventMember 2027-02-28 0001490078 PHOS:NonadjustingEventMember ifrs-full:RestrictedShareUnitsMember 2027-02-28 0001490078 2026-07-10 0001490078 ifrs-full:RestrictedShareUnitsMember 2026-03-01 2026-08-31 0001490078 ifrs-full:RestrictedShareUnitsMember 2025-03-01 2025-08-31 0001490078 ifrs-full:ShareOptionsMember 2026-03-31 0001490078 ifrs-full:ShareOptionsMember 2026-07-10 0001490078 ifrs-full:ShareOptionsMember 2026-07-08 2026-07-10 0001490078 ifrs-full:RestrictedShareUnitsMember 2025-02-28 0001490078 ifrs-full:RestrictedShareUnitsMember 2025-03-01 2025-08-31 0001490078 ifrs-full:RestrictedShareUnitsMember 2026-02-28 0001490078 PHOS:Options1Member 2026-03-01 2026-08-31 0001490078 PHOS:Options1Member 2026-08-31 0001490078 PHOS:Options2Member 2026-03-01 2026-08-31 0001490078 PHOS:Options2Member 2026-08-31 0001490078 PHOS:Options3Member 2026-03-01 2026-08-31 0001490078 PHOS:Options3Member 2026-08-31 0001490078 PHOS:Options4Member 2026-03-01 2026-08-31 0001490078 PHOS:Options4Member 2026-08-31 0001490078 PHOS:Options5Member 2026-03-01 2026-08-31 0001490078 PHOS:Options5Member 2026-08-31 0001490078 PHOS:Options6Member 2026-03-01 2026-08-31 0001490078 PHOS:Options6Member 2026-08-31 0001490078 PHOS:Options7Member 2026-03-01 2026-08-31 0001490078 PHOS:Options7Member 2026-08-31 0001490078 ifrs-full:WarrantsMember 2025-02-28 0001490078 ifrs-full:WarrantsMember 2025-03-01 2025-08-31 0001490078 ifrs-full:WarrantsMember 2025-08-31 0001490078 ifrs-full:WarrantsMember 2026-02-28 0001490078 ifrs-full:WarrantsMember 2026-03-01 2026-08-31 0001490078 ifrs-full:WarrantsMember 2026-08-31 0001490078 PHOS:WarrantsOneMember 2026-03-01 2026-08-31 0001490078 PHOS:WarrantsOneMember 2026-08-31 0001490078 PHOS:WarrantsTwoMember 2026-03-01 2026-08-31 0001490078 PHOS:WarrantsTwoMember 2026-08-31 0001490078 2023-12-29 0001490078 2026-03-01 2026-03-01 0001490078 ifrs-full:Level1OfFairValueHierarchyMember 2026-08-31 0001490078 ifrs-full:Level3OfFairValueHierarchyMember 2026-08-31 0001490078 ifrs-full:NotLaterThanOneYearMember 2026-08-31 0001490078 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2026-08-31 0001490078 2024-12-05 0001490078 2026-03-02 2026-03-04 0001490078 2026-07-25 2026-07-27 0001490078 2024-04-09 0001490078 2024-11-25 0001490078 2024-11-23 2024-11-25 0001490078 2025-07-15 2025-07-17 0001490078 PHOS:Phase1Member 2025-11-06 2025-11-07 0001490078 PHOS:Phase2Member 2025-11-06 2025-11-07 0001490078 PHOS:Phase3Member 2025-11-06 2025-11-07 0001490078 2026-09-01 0001490078 2026-09-08 2026-09-09 xbrli:shares iso4217:CAD iso4217:CAD xbrli:shares PHOS:Number iso4217:USD iso4217:EUR iso4217:GBP xbrli:pure

 

Exhibit 99.1

 

FIRST PHOSPHATE CORP.

 

Condensed Interim Consolidated Financial Statements

 

August 31, 2026

 

(Expressed in Canadian Dollars, unless otherwise noted)

 

(Unaudited – Prepared by Management)

 

1 | P a g e

 

FIRST PHOSPHATE CORP.

 

INDEX

Page
Number
   
MANAGEMENT’S RESPONSIBILITY FOR THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS 3
STATEMENTS OF FINANCIAL POSITION 4
STATEMENTS OF LOSS & COMPREHENSIVE LOSS 5
STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY 6
STATEMENTS OF CASH FLOWS 7
NOTES TO THE FINANCIAL STATEMENTS 8-28
   

 

2 | P a g e

 

 

FIRST PHOSPHATE CORP.

 

MANAGEMENT’S RESPONSIBILITY FOR THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

 

Management is responsible for the preparation and fair presentation of the accompanying condensed interim consolidated financial statements in accordance with International Accounting Standard 34, Interim Financial Reporting. This responsibility includes the design, implementation and maintenance of internal controls relevant to the preparation and fair presentation of interim financial information that is free from material misstatement, whether due to fraud or error.

 

The condensed interim consolidated financial statements include amounts based on management’s best estimates and judgments. Management has assessed the Company’s ability to continue as a going concern and has prepared the condensed interim consolidated financial statements on a going concern basis, as appropriate.

 

The Board of Directors is responsible for overseeing the Company’s financial reporting process.

 

3 | P a g e

 

 

FIRST PHOSPHATE CORP.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(Expressed in Canadian Dollars)

(Unaudited)

AS AT

 

         
Assets 

August 31, 2026

$

  

February 28, 2026

$

 
Current Assets          
           
Cash and cash equivalents (note 6)   19,949,271    20,190,457 
Restricted cash (note 6)   90,000    40,000 
Prepaid expenses (note 7)   1,714,630    1,093,593 
Tax credits/grants receivable (note 20)   5,011,536    3,348,184 
Amounts receivable   54,620    101,042 
    26,820,057    24,773,276 
Non-Current Assets          
Investments (note 8)   173,790    169,960 
Exploration and evaluation assets (note 9)   3,638,061    3,591,734 
Right-of-use assets (note 10)   144,381    120,140 
    3,956,232    3,881,834 
           
Total Assets   30,776,289    28,655,110 
           
Liabilities          
Current Liabilities          
Accounts payable and accrued liabilities   1,774,867    2,883,651 
Lease liabilities (note 11)   89,475    38,878 
Flow-through share premium liability (note 12)   2,286,955    182,800 
    4,151,297    3,105,329 
Non-current Liabilities          
Lease liabilities (note 11)   39,926    60,451 
Bridge loan (note 13)   747,246    726,213 
    787,172    786,664 
           
Total Liabilities   4,938,469    3,891,993 
           

Shareholders’ Equity

          
Capital stock (note 14)   91,282,182    72,806,008 
Contributed surplus (note 14)   6,743,688    4,874,790 
Shares to be issued (note 21(a))   334,116    100,126 
Deficit   (72,522,166)   (53,017,807)
Total Shareholders’ Equity   25,837,820    24,763,117 
           
Total Liabilities and Shareholders’ Equity   30,776,289    28,655,110 

 

Nature of operations (note 1)

Subsequent events (note 22)

 

Approved and authorized by the Board of Directors on October 15, 2026.

 

“BENNETT KURTZ” “JOHN PASSALACQUA”
  Director Director

 

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

 

4 | P a g e

 

 

FIRST PHOSPHATE CORP.

 

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS

(Expressed in Canadian Dollars)

(Unaudited)

 

                 
   For the three months ended   For the six months ended 
  

August 31,
2026

$

  

August 31,
2025

$

  

August 31,
2026

$

  

August 31,
2025

$

 
Expenses                
Mining exploration and metallurgy (note 9)   7,365,756    1,463,750    13,571,989    2,726,356 
Share based compensation (note 14 and 16)   1,116,566    423,577    2,406,412    864,968 
Business development   2,674,926    143,083    3,638,511    274,236 
Salaries and benefits   262,350    —    430,542    — 
Professional fees   157,622    100,480    477,493    192,200 
Research and development   426,438    —    891,765    — 
General and administrative (note 15)   239,345    77,391    682,752    148,966 
Regulatory and compliance   602,900    45,724    661,151    72,468 
Depreciation   15,779    —    29,326    — 
Total expenses   (12,861,682)   (2,254,005)   (22,789,941)   (4,279,194)
Other income/(expenses)                    
Government grants   494,387    —    2,196,511    — 
Interest income   150,042    17,620    246,948    30,234 
Interest expense   (12,480)   (56)   (25,281)   (103)
Financing expense   —    (232,805)   —    (332,578)
Gain on amortization of flow-through share premium liability (note 12)   718,086    463,181    862,768    823,926 
Foreign currency translation gain (note 8 and 13)   1,642    56    4,636    3,368 
Net loss and comprehensive loss   (11,510,005)   (2,006,009)   (19,504,359)   (3,754,347)
                     
Loss per common share – basic and diluted   (0.06)   (0.02)   (0.11)   (0.04)
                     
Weighted average number of common shares outstanding – basic and diluted   187,610,481    109,002,376    182,949,715    99,628,086 
                     

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

 

5 | P a g e

 

 

FIRST PHOSPHATE CORP.

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

For the six months ended August 31, 2026 and 2025

(Expressed in Canadian Dollars)

(Unaudited)

 

                          
   Common Shares   
   Number of shares  

Amount  

$

  

Contributed surplus

$

  

Shares to be issued

$

  

Deficit  

$

  

Total

$

 
Balance, February 28, 2025   89,947,551    30,657,018    5,309,401    —    (29,575,088)   6,391,331 
Shares issued   29,355,711    11,159,349    —    —    —    11,159,349 
Shares to be issued   —    —    —    4,650    —    4,650 
Flow-through share premium liability   —    (219,913)   —    —    —    (219,913)
Residual value of warrants in units issued   —    (64,550)   64,550    —    —    — 
Share issuance costs   —    (777,947)   —    —    —    (777,947)
Shares issued for finders’ fees   1,584,470    623,700    —    —    —    623,700 
Warrants issued for finders’ fees   —    —    126,647    —    —    126,647 
Share based compensation   —    —    864,968    —    —    864,968 
Shares issued upon exercise of restricted share units   2,658,780    771,046    (771,046)   —    —    — 
Net loss for the period   —    —    —    —    (3,754,347)   (3,754,347)
Balance, August 31, 2025   123,546,512    42,148,703    5,594,520    4,650    (33,329,435)   14,418,438 
                               
Balance, February 28, 2026   177,199,011    72,806,008    4,874,790    100,126    (53,017,807)   24,763,117 
Shares issued   8,849,145    17,698,290    —    —    —    17,698,290 
Shares to be issued for exploration activities   —    —    —    233,990    —    233,990 
Flow-through share premium liability   —    (2,966,923)   —    —    —    (2,966,923)
Residual value of warrants in units issued   —    (655,069)   655,069    —    —    — 
Shares issued for finders’ fees   330,960    531,640    —    —    —    531,640 
Warrants issued for finders’ fees   —    —    60,567    —    —    60,567 
Share issuance costs   —    (761,088)   —    —    —    (761,088)
Share based compensation   —    —    2,406,412    —    —    2,406,412 
Warrants exercised   2,448,939    3,178,160    (116,986)   —    —    3,061,174 
Options exercised   600,000    464,238    (149,238)   —    —    315,000 
Shares issued upon exercise of restricted share units   991,609    986,926    (986,926)   —    —    — 
Net loss for the period   —    —    —    —    (19,504,359)   (19,504,359)
Balance, August 31, 2026   190,419,664    91,282,182    6,743,688    334,116    (72,522,166)   25,837,820 

 

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

 

6 | P a g e

 

 

FIRST PHOSPHATE CORP.

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS

(Expressed in Canadian Dollars)

(Unaudited)

 

         
   For the six months ended 
  

August 31, 2026

$

   August 31, 2025
$
 
Operating Activities          
Net loss for the period   (19,504,359)   (3,754,347)
Non-cash items:          
Share based compensation   2,406,412    864,968 
Financing expense   —    332,578 
Shares to be issued for exploration activities   233,990    — 
Depreciation   29,326    — 
Interest expense   25,172    — 
Gain on amortization of flow-through share premium liability   (862,768)   (823,926)
Foreign currency translation gain   (4,636)   (3,368)
Changes in non-cash working capital items:          
Amounts receivable   46,422    (508,831)
Tax credits/grants receivable   (1,663,352)   962,634 
Prepaid expenses   (621,037)   (2,290,845)
Accounts payable and accrued liabilities   (1,108,784)   (193,199)
Restricted cash   (50,000)   (5,000)
Net cash used in Operating Activities   (21,073,614)   (5,419,317)
           
Financing Activities          
Proceeds from issuance of shares and warrants   17,698,290    11,159,349 
Share issuance costs   (168,881)   (27,600)
Proceeds from exercise of warrants   3,061,174    — 
Proceeds from exercise of options   315,000    — 
Proceeds from shares to be issued   —    4,650 
Payment of lease liabilities   (26,556)   — 
Net cash provided by Financing Activities   20,879,027    11,136,400 
           

Investing Activities

          
Payment on ROU assets   (272)   — 
Purchase of exploration and evaluation assets   (46,327)   — 
Net cash used in Investing Activities   (46,599)   — 
Net change in cash for the period   (241,186)   5,717,082 
Cash and cash equivalents, beginning of the period   20,190,457    1,873,550 
Cash and cash equivalents, end of the period   19,949,271    7,590,632 
         
Supplemental cash flow information        
Recognition of flow-through liability   2,966,923    219,913 
Shares issue for finders’ fees   531,640    623,700 
Warrants issued for finders’ fees   60,567    126,647 
Shares issued upon exercise of RSUs   986,926    771,046 
Residual value of warrants issued as part of units   655,069    64,550 
Transfer of contributed surplus upon warrant exercise   116,986    — 
Transfer of contributed surplus upon option exercise   149,238    — 

 

The Company paid $nil in taxes and $110 in interest in the six months ended August 31, 2026 (2025 - $nil and $103, respectively).

 

The Company received $293,370 in interest income in the six months ended August 31, 2026 (2025 - $30,234).

 

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

 

7 | P a g e

 

 

FIRST PHOSPHATE CORP.

Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

1.Nature of Operations

 

 

First Phosphate Corp. (the “Company”) was incorporated in British Columbia on September 18, 2006. On June 29, 2022 the Company filed articles of amendment with the Province of British Columbia changing its name from First Potash Corp. to First Phosphate Corp. The Company owns and is developing igneous rock phosphate mineral properties in the Saguenay Region of Quebec to produce phosphoric acid, which will be used to manufacture cathode active material (“CAM”) for use in lithium iron phosphate (“LFP”) batteries for the LFP battery industry.

 

The Company’s common shares are listed under the symbol “PHOS” on the Canadian Securities Exchange, “FRSPF” on the OTCQX Market and “KD0” on the Frankfurt Stock Exchange. A Level 2 American Depositary Receipt (“ADR”) trades on the Nasdaq Global Market under the symbol “PHOS,” with each ADR representing ten common shares.

 

The address of the Company’s corporate office and registered and records office is 1055 West Georgia Street, 1500 Royal Centre, P.O. Box 11117, Vancouver, British Columbia, V6E 4N7.

 

2.Going Concern

 

 

These financial statements have been prepared under IFRS Accounting Standards as issued by the International Accounting Standards Board (the “IASB”) applicable to a going concern, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of operations for the foreseeable future. Given the current stage of operations, the Company’s ability to continue as a going concern is contingent on its ability to obtain additional financing. While the Company has been successful in arranging financing in the past, the success of such initiatives cannot be assured. As of August 31, 2026, the Company has raised adequate financing that is sufficient to sustain operations for the next twelve months. Accordingly, the financial statements do not give effect to any adjustments that may be necessary should the Company be unable to continue as a going concern and, therefore, be required to realize its assets and liquidate its liabilities in other than the normal course of operations and at amounts which may differ from those shown in these financial statements. Such adjustments could be material.

 

3.Basis of Presentation

 

 

(a)Statement of compliance

 

These condensed interim consolidated financial statements have been prepared in accordance with IAS 34, Interim Financial Reporting. They do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the Company’s annual financial statements as at and for the year ended February 28, 2026 (the “Annual Financial Statements”). However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Company’s financial position and performance since the last annual financial statements as at and for the year ended February 28, 2026. These unaudited condensed interim consolidated financial statements follow the same accounting policies and methods of application as the annual financial statements.

 

8 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

These condensed interim consolidated financial statements have been prepared on a historical cost basis, except for financial instruments classified as financial instruments which are measured at fair value through profit or loss. In addition, these condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for cash flow information.

 

(b)Functional and presentation currency

 

These condensed interim consolidated financial statements are presented in Canadian dollars, which is also the functional currency of the Company, unless otherwise stated.

 

(c)Comparative figures

 

Certain comparative amounts in the condensed interim consolidated statements of loss and comprehensive loss have been reclassified to conform with the current period presentation. These reclassifications had no impact on the previously reported net loss and comprehensive loss.

 

(d)Consolidation

 

The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. Details of the controlled subsidiaries are as follows:

 

  Country of incorporation Percentage owned*
1606684 B.C. Ltd. Canada 100%

*1606684 B.C. Ltd. was incorporated on September 2, 2026, subsequent to the period end.

 

Subsidiaries are entities controlled by the Company. Control exists when the Company has power over the entity, is exposed to or has rights to variable returns from its involvement, and has the ability to use its power to affect those returns. Subsidiaries are consolidated from the date control commences until the date control ceases.

 

All intercompany balances, transactions, income and expenses, and unrealized gains and losses are eliminated on consolidation.

 

4.Material Accounting Policy Information

 

In preparing these condensed interim consolidated financial statements, the Company applied the accounting policies, critical judgments and estimates disclosed in note 3 and 4 of the annual financial statements, except as described in note 5.

 

In the opinion of management, all adjustments considered necessary for fair presentation of the Company’s financial position, results of operations and cash flows have been included. Operating results for the six months ended August 31, 2026, are not necessarily indicative of the results that may be expected for the year ending February 28, 2027.

 

9 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

5.Change in Accounting Policy

 

Presentation of government grants

 

Effective March 1, 2026, the Company changed its accounting policy for the presentation of government grants related to received or receivable. Previously, government grants were presented as a deduction from the related expenses (net presentation). Under the new policy, the related expenses are presented on a gross basis, and the government grants are presented separately as government grant income on the condensed interim consolidated statements of loss and comprehensive loss.

 

Management believes the new presentation provides more reliable and relevant information because it more transparently reflects the gross amount of the Company’s exploration, feasibility and operating expenditure and, separately, the government assistance received to offset such expenditure.

 

The change has been applied retrospectively. It affects only presentation and classification within the statement of loss and comprehensive loss and has no effect on net loss, comprehensive loss, loss per share, total assets, total liabilities, deficit or shareholders’ equity as at or for any period presented. Furthermore, this change has no effect on the comparative period for the six months ended August 31, 2025 as there was no government grant income for that period.

 

6.Cash and Cash Equivalents and Restricted Cash

 

Cash and cash equivalents includes cash held at the bank of $17,249,271 (February 28, 2026 - $10,690,457) and investments in guaranteed investment certificates (“GIC”) of $2,700,000 (February 28, 2026 - $9,500,000) which comprises of one-year cashable term GICs earning interest of 2.45% to 2.70% per annum.

 

Restricted cash is comprised of $90,000 invested in GICs (February 28, 2026 - $40,000), which are one-year cashable term GICs earning interest at 2% per annum. The GICs are held as collateral for credit cards issued to officers of the Company.

 

7.Prepaid Expenses

 

 

Prepaid expenses are comprised of the following:

 

  

August 31, 2026

$

  

February 28, 2026

$

 
Expenses paid in advance:          
Business development   863,632    727,886 
Mining exploration and metallurgy   381,351    64,825 
General administrative expenses   267,526    82,035 
Regulatory and compliance expenses   49,554    71,389 
Research and development   12,842    — 
Professional fees   139,725    147,458 
Total   1,714,630    1,093,593 

 

10 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

8.Investments

 

On January 10, 2023, the Company entered into an investment and licensing option agreement (the “IPL Agreement”) with Integrals Power Limited (“IPL”) under the terms of which the Company acquired 7,386 IPL shares for £50,000 ($83,060). Under the terms of the IPL Agreement, IPL granted an option to acquire a license to use IPL technology in a facility of a production capacity of up to 1,000-tonnes of LFP CAM for a further payment of £950,000. IPL also granted the Company another option to acquire, for an additional upfront payment of £1,000,000, a license to use IPL technology in a facility of a production capacity beyond 1,000-tonnes. The Company is committed to a 1.5% royalty per kilogram of LFP CAM sold from a facility that uses IPL technology.

 

A continuity of investments is as follows:

 

$  
Balance, February 28, 2025   168,174 
Gain on foreign currency translation   1,786 
Balance, February 28, 2026   169,960 
      
Balance, February 28, 2026   169,960 
Gain on foreign currency translation   3,830 
Balance, August 31, 2026   173,790 

 

9.Exploration and Evaluation Assets

 

 

The following details the changes in exploration and evaluation assets in the Saguenay Region of Quebec for the six-month periods ended August 31, 2025 and 2026:

 

             
   Lac`a l’Orignal
(a)
$
  

Begin- Lamarche area

flagship area
(b)
$

   Bluesky area
(c)
$
   Total
$
 
Balance as of February 28, 2025   3,270,709    321,025    —    3,591,734 
Acquisition costs   —    —    —    — 
Balance as of August 31, 2025   3,270,709    321,025    —    3,591,734 
                     
Balance as of February 28, 2026   3,270,709    321,025    —    3,591,734 
Acquisition costs   —    —    46,327    46,327 
Balance as of August 31, 2026   3,270,709    321,025    46,327    3,638,061 

 

The Company expenses non-acquisition exploration and evaluation expenditure to net income (loss). This is presented as mining exploration and metallurgy in the statement of loss and comprehensive loss. The following table details such expenditure:

 

11 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

Schedule of mining exploration and metallurgy comprehensive loss

 

 

                 
  

Lac`a l’Orignal

area
(a)
$

   Begin – Lamarche flagship area
(b)
$
  

Bluesky area

(c)

$

   Total
$
 
                 
Consulting and others   —    144,480    —    144,480 
Survey, drilling & geophysics   —    2,909,770    —    2,909,770 
Metallurgical testing   —    1,763    —    1,763 
Mining tax credits   —    (329,657)   —    (329,657)
For the six months ended August 31, 2025   —    2,726,356    —    2,726,356 
                     
Consulting and others   10,910    600,435    396,610    1,007,955 
Survey, drilling & geophysics   4,160    10,064,354    266,073    10,334,587 
Metallurgical testing   —    2,765,835    —    2,765,835 
Tax credits relating to resources   (667)   (506,405)   (29,316)   (536,388)
For the six months ended August 31, 2026   14,403    12,924,219    633,367    13,571,989 

 

(a)Lac `a l’Orignal area

 

The Lac `a l’Orignal properties consist of a series of staked claims and claims acquired under various option agreements. All of the claims are 100% owned by the Company, are free of net smelter royalties and are in good standing. This property is in the exploration stage.

 

(b)Begin - Lamarche flagship area

 

The Begin-Lamarche properties consist of a series of staked claims and claims acquired under various option agreements. All of the claims are 100% owned by the Company, are free of net smelter royalties and are in good standing. This property is in the exploration stage.

 

(c)Bluesky area

 

The Bluesky properties consist of a series of staked claims in the early exploration stage. While the Company continues to maintain certain claims in the area, the related exploration and evaluation assets have previously been impaired. During the six months ended August 31, 2026, the Company staked further claims in different areas of the property which were not staked previously to ascertain possible future economic benefit to the Company. The company will have to assess these benefits by conducting more exploration activities.

 

12 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

10.Right-Of-Use Assets

 

The following details the changes in right-of-use assets:

 

      Right-of-use assets
$
 
Balance, February 28, 2025   — 
Additions   133,617 
Depreciation for the year   (13,477)
Balance, February 28, 2026   120,140 
      
Balance, February 28, 2026   120,140 
Additions   53,567 
Depreciation for the period   (29,326)
Balance, August 31, 2026   144,381 

 

 

11.Lease Liabilities

 

 

On September 23, 2025, the Company entered into a 24-month vehicle lease agreement with a down payment and related expenses of $26,743 and monthly payments of $276. The lease has a purchase option of $35,053 at the conclusion of the 24-month lease period.

 

On November 10, 2025, the Company signed a sublease agreement, which runs for 2 years and 9 months, from December 1, 2025 to August 31, 2028, with no renewal option. The company occupies the space for free in December 2025, then pays a base monthly rent of $3,460 starting January 1, 2026.

 

At the date of initial recognition, lease liabilities were measured at the present value of remaining lease payments, discounted at an annual interest rate of 7.29%.

 

On August 5, 2026, the Company entered into a 12-month vehicle lease agreement. The lease requires monthly payments of $4,138 and a security deposit of $4,775 paid at lease commencement. The lease includes a purchase option of approximately $5,000 at the conclusion of the 12-month lease term. The lease financing rate is 4.99%, and the lease liability was measured at the present value of remaining lease payments, discounted at an annual interest rate of 4.99%.

 

13 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

The following details the changes in lease liabilities:

  

For the six months
ended August 31,

2026

$

  

For the year ended
February 28,

2026

$

 
Balance, beginning of period   99,329    — 
Recognized during the period   53,295    106,874 
Interest expense   3,333    757 
Lease payments   (26,556)   (8,302)
    129,401    99,329 
           
Balance, end of period – current   89,475    38,878 
Balance, end of period – non-current   39,926    60,451 
Balance, end of period   129,401    99,329 

 

12.Flow-Through Share Premium Liability

 

   For the six months
ended August 31, 2026
$
  

For the year ended
February 28,

2026

$

 
Balance, beginning of the period   182,800    718,477 
Liability incurred through FT shares issued   2,966,923    722,714 
Amortization for the period   (862,768)   (1,258,391)
Balance, end of the period   2,286,955    182,800 

 

As at August 31, 2026, $11,158,458 remains to be spent on qualifying expenditures (February 28, 2026 - $6,838,519).

13.Bridge Loan

 

On December 16, 2024, the Company entered into a binding letter of intent (the “LOI”) for a future phosphate concentrate offtake agreement. The LOI contemplates a minimum of 200,000 tonnes per year (with an option to increase by 20%) starting around January 1, 2029, subject to project completion. The arrangement includes a potential customer prepayment of up to €3,100,000, recoverable through purchase rebates totaling €6,200,000 over the first four years. The LOI expires on December 16, 2029, unless extended.

 

On January 5, 2026, the Company and the customer entered into an amendment to the LOI pursuant to which the customer made a prepayment of €450,000 (CA$725,580) to the Company, recognized as a bridge loan. The loan bears interest at 6% per annum and is repayable in cash if the Company does not proceed to production upon expiry of the LOI on December 16, 2029. The bridge loan has been recognized at the present value of the contingent repayment obligation, discounted at a rate of 6% over the term of 3.82 years.

 

14 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

The following details the changes in the bridge loan:

 

 

For the six months ended August 31,

2026
$

  

For the year ended February 28,

2026
$

 
Balance, beginning of the period   726,213    — 
Advance received   —    725,580 
Interest expense   21,839    993 
Effect of foreign exchange   (806)   (360)
Balance, end of the period   747,246    726,213 

 

14.Share Capital and Contributed Surplus

 

(a)Authorized shares

 

The authorized capital stock of the Company is an unlimited number of common shares and an unlimited number of preferred shares issuable in series.

 

The Company has no preferred shares outstanding.

 

(b)Common shares

 

Common share transactions are as follows:

 

During the six months ended August 31, 2026

 

(i)On March 11, 2026, the Company issued 300,000 common shares on the exercise of 300,000 options, for total proceeds of $120,000. The options’ issue date value of $90,806 was reclassified upon exercise from contributed surplus to share capital.

 

(ii)In April 2026, the Company issued 2,448,939 common shares on the exercise of 2,448,939 warrants, for total proceeds of $3,061,174. The warrants’ issue date value of $116,986 was reclassified upon exercise from contributed surplus to share capital.

 

(iii)On June 12, 2026, the Company issued 6,277,570 flow-through shares at a price of $2.00 per share, for gross proceeds of $12,555,140, with a flow-through premium deduction of $2,448,253, and 1,432,750 units at a price of $2.00 per unit, for gross proceeds of $2,865,500. Each unit was comprised of one common share and one common share purchase warrant, with each warrant exercisable for one common share at a price of $2.50 per common share until December 31, 2026, subject to an accelerated expiry clause, valued using the residual method at $558,773. In connection with the issuances, the Company paid $156,881 in cash finders’ fees, and issued 322,920 compensation shares with a fair value of $519,902 based on the fair market value of $1.61 per share and 401,360 compensation warrants with a fair value of $59,470 computed using the Black Scholes pricing model, exercisable at $2.50 per common share until December 31, 2026, subject to an accelerated expiry clause.

 

15 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

(iv)On July 10, 2026, the Company issued 960,500 flow-through shares at a price of $2.00 per share, for gross proceeds of $1,921,000, with a flow-through premium deduction of $518,670, and 178,325 units at a price of $2.00 per unit, for gross proceeds of $356,650. Each unit was comprised of one common share and one common share purchase warrant, with each warrant exercisable for one common share at a price of $2.50 per common share until December 31, 2026, subject to an accelerated expiry clause, valued using the residual method at $96,296. In connection with the issuance, the Company paid $12,000 in cash finders’ fees, and issued 8,040 compensation shares with a fair value of $11,738 based on the fair market value of $1.46 per share and 14,040 compensation warrants with a fair value of $1,097 computed using the Black Scholes pricing model, exercisable at $2.50 per common share until December 31, 2026, subject to an accelerated expiry clause.

 

(v)On July 10, 2026, the Company issued 16,475 common shares upon the exercise of RSUs, following the cancellation of 30,525 RSUs held by a consultant and the accelerated vesting of the remaining 16,475 RSUs. The RSUs’ grant date fair value of $16,310 was reclassified upon exercise from contributed surplus to share capital.

 

(vi)On August 25, 2026, the Company issued 300,000 common shares on the exercise of 300,000 options, for total proceeds of $195,000. The options’ issue date value of $58,432 was reclassified upon exercise from contributed surplus to share capital.

 

(vii)On August 31, 2026, the Company issued 975,134 common shares upon the exercise of RSUs vested to directors, management and consultants. The RSUs’ grant date fair value of $970,616 was reclassified upon exercise from contributed surplus to share capital.

 

During the six months ended August 31, 2025

 

(viii)In May 2025, the Company issued 5,041,880 flow-through shares at a price of $0.35 per share, for gross proceeds of $1,764,658, with a flow-through premium deduction of $100,838, and 1,789,990 units, at a price of $0.35 per unit, for gross proceeds of $626,497. Each unit was comprised of one common share and one half of one common share purchase warrant with each whole warrant exercisable for one common share at a price of $0.50 per common share until December 31, 2025, subject to an accelerated expiry clause, valued using the residual method at $35,800. In connection with the above private placements, the Company paid $800 in cash finders’ fees, issued 244,478 compensation shares with a fair value of $37,520 based on the fair market value of $0.33 per share for 113,697 shares, and a fair value of $47,735 based on the fair market value of $0.37 per share for 130,781 shares, and issued 218,193 compensation warrants with a fair value of $12,591 computed using the Black Scholes pricing model, exercisable at $0.50 per common share, until December 31, 2025, subject to an accelerated expiry clause.

 

16 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

(ix)On June 2, 2025, the Company issued 2,883,429 flow-through shares at a price of $0.35 per share, for gross proceeds of $1,009,200, and 334,757 units, at a price of $0.35 per unit, for gross proceeds of $117,164. Each unit is comprised of one common share and one-half of one common share purchase warrant with each whole warrant exercisable for one common share at a price of $0.50 per common share until December 31, 2025, subject to an accelerated expiry clause. In connection with the issuances, the Company issued 226,674 compensation shares with a fair value of $91,803 based on the fair market value of $0.41 per share and 226,674 compensation warrants with a fair value of $21,209 computed using the Black Scholes pricing model, exercisable at $0.50 per common share, until December 31, 2025, subject to an accelerated expiry clause.

 

(x)In July 2025, the Company issued 12,856,513 flow-through shares at a price of $0.35 per share, for gross proceeds of $4,499,780, and 550,142 units, at a price of $0.35 per unit, for gross proceeds of $192,549. Each unit is comprised of one common share and one-half of one common share purchase warrant with each whole warrant exercisable for one common share at a price of $0.50 per common share until December 31, 2025, subject to an accelerated expiry clause. In connection with the issuances, the Company paid $1,600 in cash finder’s fees, and issued 894,998 compensation shares with a fair value of $228,210 based on the fair market value of $0.36 per share for 642,844 shares, and a fair value of $114,730 based on the fair market value of $0.46 per share for 252,154 shares and 899,570 compensation warrants with a fair value of $64,680 computed using the Black Scholes pricing model, exercisable at $0.50 per common share, until December 31, 2025, subject to an accelerated expiry clause.

 

(xi)On August 21, 2025, the Company received $5,000 for the issuance of 10,000 flow-through shares at a price of $0.50 per share, with a flow-through premium deduction of $350. These shares were issued on September 12, 2025.

 

(xii)On August 22, 2025, the Company issued 4,749,000 flow-through shares at a price of $0.50 per share, for gross proceeds of $2,374,500, with a flow-through premium deduction of $118,725, and 1,150,000 units, at a price of $0.50 per unit, for gross proceeds of $575,000. Each unit is comprised of one common share and one-half of one common share purchase warrant with each whole warrant exercisable for one common share at a price of $0.50 per common share until December 31, 2025, subject to an accelerated expiry clause, valued using the residual method at $28,750. In connection with the issuances, the Company paid $25,200 in cash finder’s fees, and issued 218,320 compensation shares with a fair value of $103,702 based on the fair market value of $0.48 per share, and 268,720 compensation warrants with a fair value of $28,167 computed using the Black Scholes pricing model, exercisable at $0.50 per common share, until December 31, 2025, subject to an accelerated expiry clause.

 

(xiii)On August 31, 2025, the Company issued 2,658,780 common shares upon the exercise of RSUs for services received from its directors, management and staff. The fair value of the RSUs on the grant date was computed as $771,046 and was reclassified upon exercise from contributed surplus to capital stock.

 

17 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

(c)Omnibus Plan

 

On July 26, 2023, the Omnibus Equity Incentive Plan (the “Omnibus Plan”) was approved and adopted by the Board, which was implemented on August 25, 2023. The Omnibus Plan was amended on July 24, 2024 and was subsequently amended and re-approved by shareholders on August 28, 2026 for a further three-year term ending August 28, 2029. Under the Omnibus Plan, eligible persons may be allocated a number of Awards as the board deems appropriate, with vesting provisions also to be determined by the board. Upon vesting, eligible participants are entitled to receive cash or common shares from treasury to satisfy all or any portion of a vested RSU award. The expiry date of options granted pursuant to the Omnibus Plan is set by the board and must not be later than ten years from the date of grant. The Omnibus Plan is a “rolling” share-based compensation plan pursuant to which the aggregate number of common shares reserved for issue under the Omnibus Plan may not exceed twenty percent (20%) of the common shares issued and outstanding at the time of option or RSU grant.

 

(d)Restricted Share Units

 

On March 1, 2026, the Company granted 1,975,000 RSUs to directors, management and consultants. The RSUs vest as follows: (i) 987,500 on August 31, 2026; and (ii) 987,500 on February 28, 2027.

 

On July 10, 2026, the Company granted 51,134 RSUs to a director. The RSUs vest as follows: (i) 11,134 on August 31, 2026; and (ii) 40,000 on February 28, 2027.

 

On July 10, 2026, the Company cancelled 30,525 RSUs held by a consultant following the consultant’s resignation and accelerated the vesting of the remaining 16,475 RSUs.

 

The following details the changes in outstanding RSUs for the six months ended August 31, 2025 and 2026:

 

   Number of RSUs 
Outstanding, February 28, 2025   — 
Granted during the period   2,658,780 
Vested and exercised during the period   (2,658,780)
Outstanding, August 31, 2025   — 
      
Outstanding, February 28, 2026   — 
Granted during the period   2,026,134 
Cancelled during the period   (30,525)
Vested and exercised during the period   (991,609)
Outstanding, August 31, 2026   1,004,000 

 

For the six months ended August 31, 2026, the Company recorded $1,484,637 of share-based compensation related to the vesting of RSUs (2025 - $771,046).

 

18 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

(e)Options

 

On March 31, 2026, an officer of the Company was granted 300,000 options. The options vest at the rate of 25% every 6 months for two years following the date of grant. The options expire on December 29, 2028.

 

On July 10, 2026, a director of the Company was granted 300,000 options with an exercise price of $2.00 per share. The options vest at the rate of 25% every 6 months for two years following the date of grant and expire on December 29, 2028.

 

On July 12, 2026, the Board of Directors approved an extension of the expiry date of stock options held by a former consultant to the date that is one year after the date of termination on July 7, 2026, in accordance with the Company’s Omnibus Equity Incentive Plan.

 

The following details the changes in outstanding options for the six months ended August 31, 2025 and 2026:

 

  Number of
Options
   Weighted Average
Exercise Price
$
 
Outstanding, February 28, 2025   8,500,000    0.37 
Issued during the period   —    — 
Expired during the period   (600,000)   0.65 
Outstanding, August 31, 2025   7,900,000    0.35 
           
Outstanding, February 28, 2026   7,650,000    0.72 
Issued during the period   600,000    1.49 
Exercised during the period   (600,000)   0.53 
Outstanding, August 31, 2026   7,650,000    0.79 

 

The following is a summary of options outstanding and exercisable as of August 31, 2026:

 

                               
Expiry date  Number of
options
outstanding
   Number of
options
exercisable
   Exercise price
$
   Life remaining 
December 29, 2026   150,000    150,000    0.40    0.33 
April 16, 2027   250,000    250,000    0.40    0.63 
July 10, 2027   150,000    150,000    0.40    0.86 
December 29, 2028   1,800,000    1,800,000    0.40    2.33 
December 29, 2028   4,700,000    1,175,000    0.90    2.33 
December 29, 2028   300,000    —    0.98    2.33 
December 29, 2028   300,000    —    2.00    2.33 
    7,650,000    3,525,000           

 

19 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

For the six months ended August 31, 2026, the Company recorded $921,775 of share-based compensation related to the vesting of options (2025 - $93,922). The fair value of options issued was determined based on the Black Scholes pricing model, with the following weighted average inputs:

 

           
Weighted Averages  For the six months
ended August 31,
2026
   For the six months
ended August 31,
2025
 
Share price  $1.22    — 
Dividend yield   Nil    — 
Exercise price  $1.49    — 
Risk-free interest rate   2.82%   — 
Expected volatility   96.71%   — 
Expected expiration   2.61    — 

 

(f)Warrants

 

In April 2026, 2,169,911 warrants with an exercise price of $1.25 expired unexercised.

 

On June 12, 2026, the Company issued 1,432,750 warrants as part of the issuance of units, with each warrant exercisable for one common share at a price of $2.50 until December 31, 2026, subject to an accelerated expiry date. The warrants are valued using the residual method at $558,773. The Company also issued 401,360 finders’ warrants, with each warrant exercisable at a price of $2.50 per common share, until December 31, 2026, subject to an accelerated expiry date. The fair value of the 401,360 finders’ warrants was $59,470 computed using the Black Scholes pricing model.

 

On July 10, 2026, the Company issued 178,325 warrants as part of the issuance of units, with each warrant exercisable for one common share at a price of $2.50 until December 31, 2026, subject to an accelerated expiry date. The warrants are valued using the residual method at $96,296. The Company also issued 14,040 finders’ warrants, with each warrant exercisable at a price of $2.50 per common share, until December 31, 2026, subject to an accelerated expiry date. The fair value of the 14,040 finders’ warrants was $1,097 computed using the Black Scholes pricing model.

 

The following details the changes in outstanding warrants for the six months ended August 31, 2025 and 2026:

 

  Number of
warrants
   Weighted Average
Exercise Price
$
 
Outstanding, February 28, 2025   17,239,664    0.54 
Issued during the period   3,525,601    0.50 
Outstanding, August 31, 2025   20,765,265    0.53 
           
Outstanding, February 28, 2026   7,243,850    0.94 
Issued during the period   2,026,475    2.50 
Expired during the period   (2,169,911)   1.25 
Exercised during the period   (2,448,939)   1.25 
Outstanding, August 31, 2026   4,651,475    1.31 

 

20 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

The following is a summary of warrants outstanding and exercisable as at August 31, 2026:

 

                               
Expiry date  Number of warrants outstanding   Number of warrants exercisable   Exercise price
$
   Weighted average life remaining 
December 31, 2026   2,026,475    2,026,475    2.50    0.33 
December 30, 2028   2,625,000    2,625,000    0.40    2.33 
    4,651,475    4,651,475           

 

15.General and Administrative Expenses

 

 

General and administrative expenses are comprised of the following:

 Schedule of general and administrative expenses

         
   For the six months ended 
  

August 31, 2026 

$

  

August 31, 2025

$

 
Office   137,005    22,076 
Travel   362,618    126,403 
IT and telecom expenses   112,129    487 
Management fees   71,000    — 
Total   682,752    148,966 

 

16.Related Party Transactions

 

 

Related parties and related party transactions impacting the accompanying financial statements are summarized below and include transactions with the following individuals or entities:

 

Key management personnel

 

Key management personnel include those persons having authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The Company has determined that key management personnel consist of executive and non-executive members of the Company’s Board of Directors and corporate officers.

 

Key management personnel compensation is comprised of:

 

                 
   For the three months ended   For the six months ended 
   August 31, 2026
$
   August 31, 2025
$
   August 31, 2026
$
   August 31, 2025
$
 
Share based compensation   722,137    198,820    1,533,069    436,376 
Financing fees   —    232,804    —    332,578 
Management fees   45,500    —    71,000    — 
    767,637    431,624    1,604,069    768,954 

 

21 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

There are no amounts owed to related parties as of August 31, 2026.

 

The financing fees relate to the amortization of a prepaid financing expense arising from warrants issued to key management personnel and directors in connection with a $2.1 million revolving credit facility entered into on December 29, 2023. The vested warrants had a fair value of $798,188, which was capitalized as a prepaid financing expense and amortized over the term of the facility. As the facility expired on December 29, 2025 without being utilized, the remaining unamortized balance was fully expensed during the year ended February 28, 2026.

 

On March 1, 2026, the Company granted 1,281,000 RSUs to directors and management. The RSUs vest as follows: (i) 640,500 on August 31, 2026; and (ii) 640,500 on February 28, 2027.

 

On July 10, 2026, the Company granted 51,134 RSUs to a director, The RSUs vest as follows: (i) 11,134 on August 31, 2026; and (ii) 40,000 on February 28, 2027. On the same date, the director was granted 300,000 options with an exercise price of $2.00 per share. The options vest at a rate of 25% every 6 months for two years following the date of grant and expire on December 29, 2028.

 

17.Financial Instruments

 

 

Financial instruments are agreements between two parties that result in promises to pay or receive cash or equity instruments. The Company classifies its financial instruments as follows: cash and cash equivalents, and investments at FVTPL and restricted cash and accounts payable at amortized cost. The carrying values of these instruments approximate their fair values due to their short term to maturity.

 

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of fair value hierarchy are:

 

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities;

Level 2 – Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and

Level 3 – Inputs that are not based on observable market data.

 

The following table sets forth the Company’s financial assets measured at fair value by levels within the fair value hierarchy:

 

                    As at August 31, 2026
  

Level 1

$

  

Level 2

$

  

Level 3

$

   Total
$
 
Cash and cash equivalents   19,949,271            19,949,271 
Long-term investments             173,790    173,790 

 

22 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

The investments in Level 3 include the investment in privately held companies that are not quoted on an exchange. Management believes that the price of the shares in the investee’s most recent private placement approximates the fair value.

 

The Company is exposed in varying degrees to a variety of financial instrument related risks:

 

Credit risk

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company is exposed to a significant credit risk as its maximum exposure relates to cash and restricted cash totaling $20,039,271. The Company mitigates the credit risk of cash by depositing with only reputable financial institutions. The Company also assesses the credit quality of counterparties, taking into account their financial position, past experience and other factors.

 

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due.

 

The Company as at August 31, 2026, has $19,949,271 in cash and cash equivalents and $90,000 in restricted cash and $2,651,514 in financial liabilities, consisting of $1,774,867 in accounts payable and accrued liabilities, $129,401 in lease liabilities, and $747,246 in bridge loans, which represents the Company’s maximum exposure to liquidity risk.

 

The following table summarizes the Company’s financial liabilities as at August 31, 2026:

Financial liabilities  Due ≤ 1 year
$
   Due 2–5 years
$
   Total carrying amount
$
 
Accounts payable and accrued liabilities   1,774,867    —    1,774,867 
Lease liabilities (note 10)   89,475    39,926    129,401 
Bridge loan (note 12)   —    747,246    747,246 
Total   1,864,342    787,172    2,651,514 

 

Market risk 

Market risk is the risk of loss that may arise from changes in market factors such as interest rates, foreign exchange rates, and commodity and equity prices. The Company is not exposed to material market risk. 

 

(a)Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.

 

23 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

The risk that the Company will realize a loss as a result of a change in the interest rate is low, as the Company has no investments or liabilities with variable interest rates.

 

(b)Foreign currency risk

Foreign currency risk is the risk that the fair value of future cash flows of the Company’s financial instruments will fluctuate as a result of changes in foreign exchange rates. As of August 31, 2026, a portion of the Company’s financial assets, comprising long-term investments, are held in Great British Pound (“GBP”). 1% change in the exchange rate would result in a change of net loss or gain by $1,738. In addition, a portion of the Company’s financial liabilities, comprising bridge loans, are held in Euro (“EUR”). 1% change in the exchange rate would result in a change of net loss or gain by $7,472. The impact of fluctuations in foreign exchange rates is not significant and, accordingly, a sensitivity analysis has not been provided.

 

(c)Price risk

Price risk is related to equity and commodity price risks. Equity price risk is defined as the potential adverse impact on the Company’s earnings due to movements in individual equity prices or general movements in the level of the stock market. Commodity price risk is defined as the potential adverse impact on earnings and economic value due to commodity price movements and volatilities. As the Company holds no significant equity or commodity related investments or assets, the Company has minimal exposure to price risk.

 

18.Capital Risk Management

 

 

The Company considers its capital to be comprised of shareholders’ equity.

 

The Company manages the capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares. Although the Company has been successful at raising funds in the past through the issuance of capital stock, it is uncertain whether it will continue this method of financing due to the current difficult market conditions.

 

In order to facilitate the management of its capital requirements, the Company prepares expenditure budgets that are updated as necessary depending on various factors, including successful capital deployment and general industry conditions.

 

Management reviews the capital structure on a regular basis to ensure that the above objectives are met. There have been no changes to the Company’s approach to capital management during the period ended August 31, 2026. The Company is not subject to externally imposed capital requirements.

 

19.Segmented Information

 

 

The Company has one operating segment involved in the exploration of mineral properties. All of the Company’s operations and long-lived assets are in Canada.

 

24 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

20.Government Grants and Tax Credits

 

 

The following table summarizes the Company’s taxes recoverable and government grants and tax credits receivable:

  

As at August 31,

2026
$

  

As at February 28,

2026
$

 
Mining tax credits receivable   2,336,013    1,799,625 
Government grants receivable   1,463,356    410,371 
GST/HST/QST recoverable   1,212,167    1,138,188 
Total tax credits/grants receivable   5,011,536    3,348,184 

 

The Company is entitled to refundable mining tax credits on qualified exploration expenditures incurred in Quebec.

 

Promotion Saguenay 

On December 5, 2024, the Company was awarded a $75,000 grant from Promotion Saguenay to reimburse eligible expenses related to a feasibility study for the construction of an iron phosphate plant. In the year ended February 28, 2025, $37,500 had been recognized by the Company as government grant income within other income on the condensed interim consolidated statements of loss and comprehensive loss. During six months ended August 31, 2026, the remaining $37,500 was received and recognized by the Company as government grant income on the condensed interim consolidated statements of loss and comprehensive loss.

 

National Resources Canada (“NRCan”) 

On March 4, 2026, the Company executed a definitive contribution agreement with NRCan for funding related to a feasibility study for the production of lithium-iron-phosphate cathode active material and received approval for the reimbursement of up to $16,717,722 of eligible expenditures incurred between January 9, 2026 and March 31, 2028. For the year ended February 28, 2026, the Company recorded claims under this grant of $410,371, of which $410,371 has been received. During the six months ended August 31, 2026, the Company recorded claims under this grant of $2,034,893 (August 31, 2025 - $nil), of which $695,654 has been received. The amount has been recognized by the Company as government grant income on the condensed interim consolidated statements of loss and comprehensive loss. As at August 31, 2026, the remaining $14,272,458 has not been accrued as a receivable as the Company has determined that there is still collection uncertainty at the reporting date.

 

First and Last Mile Fund (“CMIF”) 

On July 27, 2026, the Company executed two non-repayable contribution agreements with NRCan under the First and Last Mile Fund program. The first agreement supports the electrical transmission line for the sustainable exploitation of the Begin-Lamarche phosphate deposit and provides a contribution equal to the lesser of 50% of total eligible project expenditures and $3,071,587, for eligible expenditures incurred between April 1, 2026 and March 31, 2030. The second agreement supports the road infrastructure for the same deposit and provides a contribution equal to the lesser of 50% of total eligible project expenditures and $1,771,350, for eligible expenditures incurred between April 1, 2026 and March 31, 2029. During the six months ended August 31, 2026, the Company recorded a receivable of $124,117 (August 31, 2025 - $nil) for amounts expected to be recoverable under these agreements, of which $nil has been received.

 

25 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

The following details the changes in refundable tax credits and government grants receivable:

 

  

For the six months ended
August 31,

2026
$

  

For the year ended
February 28,

2026
$

 
Tax credits/grants receivable, beginning of the period   2,209,996    1,244,955 
Mining tax credits accrued   536,388    1,799,625 
Grants accrued   2,196,510    412,871 
Tax credits received   —    (1,244,955)
Grants received   (1,143,525)   (2,500)
Tax credits/grants receivable, end of the period   3,799,369    2,209,996 

 

21.Commitments

 

 

(a)Pekuakamiulnuatsh First Nation Agreement

 

On April 9, 2024, the Company entered into a collaboration agreement with the Pekuakamiulnuatsh First Nation (“PFN”) (the “Collaboration Agreement”). The Collaboration Agreement is intended to establish the respective commitments of both parties with respect to exploration and development activities at the Company’s mineral properties. The Collaboration Agreement remains in effect until the earlier of a) the signing of an Impact and Benefit Agreement (“IBA”); or b) the dissolution by mutual written consent of both parties. Upon signing the Collaboration Agreement, the Company issued 100,000 common shares to PFN as a good-faith payment. Each year, 2.5% of the expenses related to the exploration and development activities carried out (drilling and related work) on the mineral properties is to be paid to PFN in the form of common shares of the Company based on the market price of the common shares on December 31 of the year in question and payable by January 20 of the following year. Until the IBA is signed, the Company is to issue a minimum payment of 100,000 common shares per calendar year payable by January 15 of the current year. During the year ended February 28, 2026, the Company issued 240,132 common shares to PFN in satisfaction of the 2025 annual expenses and minimum payment for 2026, and accrued $100,126 for shares to be issued based on relevant expenses incurred. For the six months ended August 31, 2026, the Company accrued $233,990 for shares to be issued based on relevant expenses incurred.

 

(b)Technology Licensing Agreement

 

On November 25, 2024, the Company entered into a technology licensing agreement (the “Technology Agreement”) with an arm’s length party to license certain technologies (the “Technology”) related to the production of phosphoric acid at a cost to the Company of €100,000. As at February 28, 2026, the signing fee of €100,000 had been fully paid.

 

26 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

Upon the satisfaction of certain conditions, the Company is to have an option to acquire the non-exclusive rights to utilize the Technology for a further payment of €3,000,000. If annual production of phosphoric acid using the Technology exceeds contractual thresholds, the Company is to pay an additional fee of €500 per metric ton of excess production.

 

(c)Land Option Agreement

 

On July 17, 2025, the Company entered into a land option agreement (the “Option Agreement”) with the Saguenay Port Authority (the “Port”) under which the Port granted the Company an exclusive option to enter into a definitive long-term industrial lease for two parcels of land owned by the Port within the Saguenay Industrial and Port Zone (the “Phase 1 Site” and the “Phase 2 Site”). The option is intended to secure the land required for the Company’s planned purified phosphoric acid plant.

 

The Option Agreement is valid from the date of signature until December 31, 2027, subject to extension by mutual written agreement for additional periods of three months. Option fees in respect of the Phase 1 Site are payable as follows: (i) from signature to December 31, 2025, $nil; (ii) for the 2026 calendar year, the fee is $0.50 per m² per year, subject to annual indexation and payable quarterly in advance; and (iii) for the 2027 calendar year, the fee is $1.00 per m² per year, subject to annual indexation and payable quarterly in advance.

 

For the six months ended August 31, 2026, the Company recorded $102,737 in research and development expenses on the condensed interim consolidated statements of loss and comprehensive loss. Amounts payable under the option agreement as at August 31, 2026 are $nil.

 

The option fee for the Phase 2 Site is free of charge until the Company exercises its option or right of first refusal over that site, at which point it becomes payable at the rate then in force.

 

The Company’s ability to maintain the option beyond June 30, 2026 was conditional on demonstrating to the Port that US$15 million of financing dedicated to the project had been secured. During the six months ended August 31, 2026, the Company secured adequate financing to satisfy this condition. The Company’s ability to maintain the option beyond December 31, 2026 remains conditional upon demonstrating that total financing of US$37 million has been secured and that the licensing, feasibility and authorization milestones set out in the agreement have been completed or are in progress. No later than September 1, 2027, the Company must notify the Port whether it is exercising the option to negotiate a long-term lease, to be entered into no later than January 1, 2028. Option fees paid are non-refundable and do not constitute rent or an advance on rent.

 

(d)Ultion Technologies Agreement

 

On November 7, 2025, the Company agreed to Phase 1 of a three-phase proposal dated November 6, 2025 from Ultion Technologies Inc. (“Ultion”) for the feasibility, design, equipment sourcing, and start-up of a LFP CAM production plant in North America.

 

Phase 1 covers feasibility work and preparation of the technology document package for a total cost of US$650,000, payable as to US$350,000 upon approval of Phase 1 and US$300,000 upon finalization of the feasibility information and preparation and secure storage of all technology documents. The Company has paid US$350,000 upon approval of Phase 1 in the year ended February 28, 2026 and paid the remaining US$300,000 upon finalization of the Phase 1 deliverables in the three months ended May 31, 2026, for total payments of US$650,000.

 

27 | P a g e

 

 

FIRST PHOSPHATE CORP.
Notes to the Condensed Interim Consolidated Financial Statements

August 31, 2026

(Expressed in Canadian Dollars)

(Unaudited)

 

 

 

Phases 2 and 3 of the proposal, which relate to detailed engineering design and equipment sourcing and to plant start-up and operations, are estimated by Ultion at US$5.65 million plus optional services and US$1.5 million, respectively. Each remains subject to separate written acceptance by the Company and, as at August 31, 2026, had not been approved or committed to. Accordingly, no obligation in respect of Phases 2 and 3 has been recognized or is included in the commitment above.

 

22.Subsequent Events

 

 

On September 1, 2026, the Company cancelled 61,500 RSUs held by a consultant.

 

On September 2, 2026, the Company incorporated a wholly owned subsidiary, 1606684 B.C. Ltd.

 

On September 9, 2026, the Company acquired a cottage and related leasehold rights located in Québec for consideration of $324,273.

 

28 | P a g e

 

Exhibit 99.2

 

FORM 51-102F1

MANAGEMENT DISCUSSION AND ANALYSIS

FIRST PHOSPHATE CORP.

FOR THE THREE AND SIX MONTHS ENDED AUGUST 31, 2026 AND 2025

 

This management’s discussion and analysis (“MD&A”) covers the consolidated financial statements of First Phosphate Corp. (the “Company” or “First Phosphate”) for the period ended August 31, 2026 and for the comparable period ended August 31, 2025. This MD&A should be read in conjunction with the condensed interim consolidated financial statements and notes thereto as at and for the period ended August 31, 2026 and August 31, 2025 (the “Interim Financial Statements”). The information contained in this report is current to October 15, 2026 and has been approved by the Company’s board of directors (the “Board”).

 

This discussion should be read in conjunction with the Company’s audited annual financial statements for the years ended February 28, 2026 and February 28, 2025, together with the notes thereto. Results are reported in Canadian dollars, unless otherwise noted. The Company’s financial statements and the financial information contained in the MD&A are prepared in accordance with IFRS Accounting Standards (“IFRS”) as issued by the International Accounting Standards Board and interpretations of the IFRS Interpretations Committee.

 

The Company’s certifying officers are responsible for ensuring that the condensed interim consolidated financial statements and MD&A do not contain any untrue statement of material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made. The Company’s officers certify that the condensed interim consolidated financial statements and MD&A fairly present, in all material respects, the financial condition, result of operations and cash flows, of the Company as of the date hereof.

 

The Board approves the condensed interim consolidated financial statements and MD&A and ensures that the Company’s officers have discharged their financial responsibilities. The Board’s review is accomplished principally through the Audit Committee, which reviews and approves all financial reports prior to filing.

 

Additional information related to the Company is available on SEDAR+ at www.sedarplus.com.

 

DESCRIPTION OF BUSINESS AND OVERVIEW

 

The Company was incorporated in British Columbia on September 18, 2006. On June 29, 2022 the Company filed articles of amendment with the Province of British Columbia changing its name from First Potash Corp. to First Phosphate Corp. The address of the Company’s head office is 181 Bay St. Ste 4400, Toronto, ON M5J 2V8 and the address of its registered and records office is 1055 West Georgia Street, 1500 Royal Centre, P.O. Box 11117, Vancouver, British Columbia, V6E 4N7.

 

First Phosphate is a mineral exploration and development and clean technology company dedicated to building and reshoring a vertically integrated mine-to-market supply chain for the production of lithium iron phosphate (“LFP”) batteries in North America. Target markets include energy storage, data centers, robotics, mobility, and national security. First Phosphate's flagship Bégin-Lamarche property (the “Bégin-Lamarche Property”), located in Saguenay-Lac-Saint Jean, Québec, Canada, represents a rare North American igneous phosphate resource producing high purity phosphate characterized by very low levels of impurities. Since May 2022 the Company has been in the business of acquiring, exploring and developing igneous anorthosite rock mineral properties in the Saguenay-Lac-St-Jean Region of Quebec. The Company currently holds a number of royalty free Exclusive Exploration Rights, or EER, in the region of Saguenay-Lac-St-Jean. Within these holdings, the Company has two primary properties for the purpose of exploration and future development being the Bégin-Lamarche Property and the Lac à l'Orignal property (the “Lac à l'Orignal Property”), as well as a series of staked claims within 250km of the Port of Saguenay (the “Bluesky Areas”, and collectively, the “Areas”). None of the Properties have generated revenues to date.

 

 

 

The Company’s mining exploration properties are located in Quebec, a North American electrification industry hub. The properties are strategically located in proximity to the Chicoutimi – Jonquiere population centre, Quebec’s 5th largest population centre, with a skilled industrial workforce. The Saguenay-Bagotville Airport is within approximately 77km from the Bégin-Lamarche Property, with daily flights to Montreal. The Company has road access to the deep-sea Port of Saguenay for international shipment of its concentrates as well as the ability to build industrial facilities at the Port of Saguenay. Clean Quebec Hydro is present in the vicinity of many of the Company’s mining claims as well as at the Port of Saguenay. The Company’s flagship Bégin-Lamarche Property as well as the Lac à l’Orignal Property are located on four-season, heavy haul gravel roads connected to a paved provincial highway and to the Port of Saguenay.

 

In addition to its core extraction development activities, the Company is simultaneously identifying and evaluating downstream phosphate processing opportunities. Specifically, the Company is currently working towards the development of a 190,000 tonne per annum phosphoric acid plant (the “Phosphoric Acid Plant”), and an Iron Phosphate pre-CAM/LFP CAM plant (“First Saguenay”, and collectively, the “Proposed Downstream Facilities”). The Proposed Downstream Facilities are in the planning and development stages.

 

Industry Developments

 

The global LFP battery market size was USD 19.07 billion in 2024 and is projected to reach USD 124.42 billion by 2032 at a compound annual growth rate of 25.6%. Fortune Business Insights™ has mentioned these insights in its research report, titled, “Lithium Iron Phosphate Battery Market Size, Share & Industry Analysis, 2024-2032.”

 

Changes in Share Capital

 

a)On March 11, 2026, the Company issued 300,000 common shares on the exercise of 300,000 options, at $0.40 per share, for total proceeds of $120,000. The options’ issue date value of $90,806 was reclassified upon exercise from contributed surplus to share capital.

 

b)In April 2026, the Company issued 2,448,939 common shares, at $1.25 per share, on the exercise of 2,448,939 warrants, for total proceeds of $3,061,174. The warrants’ issue date value of $116,986 was reclassified upon exercise from contributed surplus to share capital.

 

c)In June to July 2026, the Company issued an aggregate of 7,238,070 flow-through shares at a price of $2.00 per share for gross proceeds of $14,476,140, with a flow-through premium deduction of $2,966,923, and 1,611,075 units at a price of $2.00 per unit for gross proceeds of $3,222,150. Each unit comprised one common share and one common share purchase warrant, with each warrant exercisable for one common share at a price of $2.50 until December 31, 2026, subject to an accelerated expiry clause. The warrants issued as part of the units were valued using the residual method at an aggregate of $655,069. In connection with the issuances, the Company paid $168,881 in cash finders’ fees and issued 330,960 compensation shares with an aggregate fair value of $531,640, based on the fair market value of the common shares on the respective issuance dates, and 415,400 compensation warrants with an aggregate fair value of $60,567, computed using the Black-Scholes pricing model. The compensation warrants are exercisable at $2.50 per common share until December 31, 2026, subject to an accelerated expiry clause.

 

2

 

d)On July 10, 2026, the Company issued 16,475 common shares upon the exercise of Restricted Share Units (“RSUs”), following the cancellation of 30,525 RSUs held by a consultant and the accelerated vesting of the remaining 16,475 RSUs. The RSUs' grant date fair value of $16,310 was reclassified upon exercise from contributed surplus to share capital.

 

e)On August 25, 2026, the Company issued 300,000 common shares on the exercise of 300,000 options, for total proceeds of $195,000. The options' issue date value of $58,432 was reclassified upon exercise from contributed surplus to share capital.

 

f)On August 31, 2026, the Company issued 975,134 common shares upon the exercise of RSUs vested to directors, management and consultants. The RSUs' grant date fair value of $970,616 was reclassified upon exercise from contributed surplus to share capital.

 

Other Events

 

March 1, 2026: On March 1, 2026, the Company granted 1,975,000 RSUs to directors, management and consultants. The RSUs vest as follows: (i) 987,500 on August 31, 2026; and (ii) 987,500 on February 28, 2027.

 

March 4, 2026: The Company finalized an agreement for a $16.7 million non-repayable contribution from the Government of Canada through Natural Resources Canada (“NRCan”) Global Partnerships Initiative (the “NRCan Grant”) to support technical and engineering studies to validate the production of phosphate concentrate.

 

March 31, 2026: An officer of the Company was granted 300,000 options. The options vest at the rate of 25% every 6 months for two years following the date of grant. The options expire on December 29, 2028.

 

March 31, 2026: Gilles Laverdière retired as Chief Geologist of the Company and was succeeded by Steeve Lavoie, who was appointed effective April 1, 2026.

 

April 2026: 2,169,911 warrants with an exercise price of $1.25 expired unexercised.

 

June 17, 2026: The Company formalized international investment and offtake agreements under the Critical Minerals Resilience and Production Alliance at the 52nd G7 Summit in Évian, France and received letters of interest from export credit agencies, financial institutions and industrial partners.

 

July 10, 2026: The Company cancelled 30,525 RSUs held by a consultant following the consultant's resignation and accelerated the vesting of 16,475 RSUs. On the same day, the Company issued 16,475 common shares upon the exercise of 16,475 RSUs. On July 12, 2026, the Board approved an extension of the expiry date of stock options held by the former consultant to the date that is one year after the Date of Termination on July 7, 2026, in accordance with the Company's Omnibus Equity Compensation Plan.

 

July 10, 2026: Peter Kent was appointed as a director of the Company. The Company granted Mr. Kent: (a) 51,134 RSUs that vest as follows: (i) 11,134 on August 31, 2026, and (ii) 40,000 on February 28, 2027; and (b) 300,000 options with an exercise price of $2 per share. The options vest at the rate of 25% every 6 months for two years following the date of grant and expire on December 29, 2028.

 

3

 

 

July 27, 2026: The Company's Bégin-Lamarche Property was selected for "Filon" support status by the Québec Ministry of Natural Resources and Forests ("MRNF").

 

July 27, 2026: The Company executed two non-repayable contribution agreements with NRCan under the First and Last Mile Fund (“CMIF”) program. The first agreement supports the electrical transmission line for the sustainable exploitation of the Begin-Lamarche phosphate deposit and provides a contribution equal to the lesser of 50% of total eligible project expenditures and $3,071,587, for eligible expenditures incurred between April 1, 2026 and March 31, 2030. The second agreement supports the road infrastructure for the same deposit and provides a contribution equal to the lesser of 50% of total eligible project expenditures and $1,771,350, for eligible expenditures incurred between April 1, 2026 and March 31, 2029.

 

August 10, 2026: The Company's Level 2 American Depositary Receipts ("ADRs") commenced trading on the Nasdaq Global Market under the ticker symbol "PHOS", with each ADR representing ten common shares.

 

Subsequent Events

 

September 1, 2026: The Company cancelled 61,500 RSUs held by a consultant.

 

September 2, 2026: The Company incorporated a wholly owned subsidiary, 1606684 B.C. Ltd.

 

September 9, 2026: The Company acquired a cottage and related leasehold rights located in Québec for consideration of $324,273.

 

PROJECT DEVELOPMENT PLANS AND MINERAL PROPERTIES

 

Bégin - Lamarche Property:

 

Overview

 

The Bégin-Lamarche Property is the Company's flagship phosphate development asset located in the Saguenay-Lac-Saint-Jean region of Québec. The project is supported by an updated mineral resource estimate, dated effective May 1, 2026 (the “Updated Bégin-Lamarche MRE”), and a preliminary economic assessment (the “Bégin-Lamarche PEA”), dated effective December 4, 2024, which evaluated a potential open-pit phosphate concentrate operation. The Bégin-Lamarche Property remains the principal focus of the Company's exploration and development activities.

 

The Deposit is located next to existing road and hydroelectric infrastructure and only 70km driving distance from the deep-sea Port of Saguenay. The deposit benefits from definitive, long-term, partially prepaid offtake from an existing, creditworthy partner. Apatite (phosphorus, phosphate) is listed on the critical minerals lists of Québec, Canada, the United States and the European Union.

 

4

 

The Updated Bégin-Lamarche MRE concludes that the Bégin-Lamarche Property phosphate deposit (the “Deposit”) contains a significant phosphate Mineral Resource that is associated with well-defined oxide-apatite peridotite (OAP) intrusions within the large Lac-Saint-Jean anorthosite suite. The phosphate deposit is comprised of four mineralized zones which are continuous, only separated by faults within the Deposit and extend over a length of 2,750 m (Figure 1). The Mountain Zone is a single phosphate-bearing mass having a diameter of up to 200 m and a length of 250 m. The Northern zone is comprised of four phosphate layers ranging from 30 m to 200 m in thickness and a length of 625 m. The Central Zone bears eight phosphate layers, one of them having up to 50 m in thickness and extending to 900 m. The Southern Zone bears three phosphate layers, one of them having up to 125 m in thickness and extending to 725 m. The following are among the reported results from the Updated Bégin-Lamarche MRE:

 

●Measured pit-constrained Mineral Resource: 6.2 Mt @ 7.70% P2O5 (phosphate).

●Indicated pit-constrained Mineral Resource: 198.5 Mt @ 6.00% P2O5.

●Inferred pit-constrained Mineral Resource: 89.5 Mt @ 6.16% P2O5.

●The Deposit remains open at depth.

●Metallurgical test work indicates an anticipated apatite concentrate grade of 40.4% P2O5 at an 88% process recovery rate, with very low levels of potentially deleterious elements, and has been qualified for production of battery-grade phosphoric acid for lithium iron phosphate (“LFP”) battery with a conversion ratio of 91.1%.

 

The results of the Bégin-Lamarche PEA were based on a Mineral Resource Estimate that included phosphate, iron (magnetite) and titanium resource calculations. More precisely, the economics of the Bégin-Lamarche PEA considered only phosphate and magnetite processing and not titanium processing. Furthermore, the Updated Bégin-Lamarche MRE included only a phosphate Mineral Resource calculation and not any iron (magnetite) and titanium Mineral Resource calculations. For this reason, if an updated Bégin-Lamarche PEA were prepared today using the Updated Bégin-Lamarche MRE and its corresponding resource calculations, the economic and operational results would differ from those presented in the existing Bégin-Lamarche PEA. This would be a result of, amongst other things, the removal from the financial model of any magnetite processing stream, and its projected revenues and associated operational expenditures. The Company does not believe the net economic impact from the removal of a magnetite processing stream to be material to the overall project economics of the Bégin-Lamarche Property. Lastly, the processing of a phosphate stream remains unaffected and not contingent upon, the processing of a magnetite or a titanium stream.

 

Development Plan

 

The Board has determined that the Mineral Resource at the Bégin-Lamarche Property is sufficiently well defined to commence the preparation of a Feasibility Study on the property with an targeted completion date of calendar Q1, 2027.

 

Activities During the Period

 

During the six months ended August 31, 2026, the Company continued exploration and technical programs including drilling activities and associated geological and technical work. On May 26, 2026, the Company announced the Updated Bégin-Lamarche Property MRE.

 

Project Expenditures and Advancement

 

Mining exploration and metallurgy expenditures attributable to the Bégin-Lamarche Property totaled $12,924,219 during the six months ended August 31, 2026. These expenditures related principally to drilling activities and associated mineralogy to advance geological understanding of the resources.

 

Next Steps

 

For the next 12 months, the Company estimates a spending of $5,906,890 for engineering and other activities related to the preparation of the Feasibility Study, and permitting (net of non-dilutive governments contributions). These expenditures are expected to be funded from the Company’s current working capital. The Company has not budgeted additional amounts for exploration or drilling activities on or related to the Bégin-Lamarche Property.

 

5

 

Lac à l’Orignal Property:

 

Overview

 

The Lac à l'Orignal Property is a phosphate project located in Québec that is subject to a preliminary economic assessment dated effective July 25, 2023 (the “Lac à l’Orignal PEA”). The Lac à l’Orignal PEA provides a viable case for developing the property by open pit mining for the primary production of a phosphate concentrate and secondary recovery of magnetite and ilmenite concentrates. The Lac à l’Orignal PEA is preliminary in nature and includes Inferred Mineral Resources that are considered too speculative geologically to have the economic considerations applied to them that would enable them to be classified as Mineral Reserves. Mineral Resources are not Mineral Reserves and do not have demonstrated economic viability.

 

Development Plan

 

The Company intends to maintain the Lac à l'Orignal Property while prioritizing exploration and development resources toward the Bégin-Lamarche Property and the Bluesky Areas.

 

Activities During the Period

 

For the six months ended August 31, 2026, expenditures associated with the Lac à l'Orignal Property totaled $14,403. No significant exploration or development milestones were disclosed during the period.

 

Project Expenditures and Advancement

 

The Company intends to expend all maintenance amounts necessary to maintain its interests in the Lac à l'Orignal Property until a decision is made regarding any future developments on the property.

 

Next Steps

 

The Company has not had any material development milestones or significant exploration programs for the Lac à l'Orignal Property beyond ongoing evaluation and maintenance activities.

 

Bluesky Areas:

 

Overview

 

The Bluesky Areas consist of a series of staked claims areas within 250 km or less from the Port of Saguenay, Quebec.

 

Development Plan

 

The Company's objective during the period was to evaluate the exploration potential of different Bluesky areas through prospecting and drilling activities. The Company will allocate additional amounts for ongoing surface sampling, prospecting and other forms of reconnaissance as deemed appropriate from time to time.

 

6

 

Activities During the Period

 

During the six months ended August 31, 2026, the Company incurred $633,367 of expenditures relating primarily to prospecting and drilling activities in the Bluesky areas. These expenditures supported exploration assessment of the areas and the evaluation of its future development potential.

 

Project Expenditures and Advancement

 

The exploration work completed during the period enabled management to evaluate the areas’ relative strategic importance within the Company's broader portfolio of phosphate assets.

 

Next Steps

 

The Company estimates a spending of $4.7 million for the exploration of these areas. Additional expenditures and milestones will be determined on an ongoing basis upon receipt and analysis of results from initial geological activities.

 

Proposed Downstream Facilities

 

Phosphoric Acid Plant:

 

Overview

 

The proposed Phosphoric Acid Plant forms part of the Company's long-term downstream processing strategy. The Company is evaluating development of a phosphoric acid production facility.

 

Development Plan

 

The Company has entered into an industrial land option agreement with the Port of Saguenay (the “Port”) for the site of the development of its downstream Phosphoric Acid Plant. Under this agreement, First Phosphate has the exclusive right to enter into a definitive land lease with the Port by December 31, 2027, subject to various financial and development milestones. The Phosphoric Acid Plant is to use advanced clean technology from Prayon Technologies and be implemented by international engineering firm Ballestra Spa.

 

Activities During the Period

 

The Company continued evaluating the proposed Phosphoric Acid Plant as part of its downstream phosphate processing strategy. The Company satisfied the first condition under the option with Port of Saguenay by raising US $15 million, prior to June 30, 2026, dedicated to the development of its apatite mine and a phosphoric acid plant (the “Project”).

 

Project Expenditures and Advancement

 

No material project-specific expenditures were incurred during the period. The Phosphoric Acid Plant remains in the evaluation and planning stage.

 

Next Steps

 

The company is weighing the next steps for the feasibility studies required for the development of these facilities.

 

7

 

First Saguenay Project:

 

Overview

 

The First Saguenay Project forms part of the Company's strategy to participate in the North American lithium iron phosphate battery supply chain through downstream phosphate processing activities. Funding costs for the complete facility were estimated at US$70 million in September 2024.

 

Development Plan

 

The Company is currently waiting for clarity on the impact of the North American trade-tariff situation and other geopolitical factors before assessing further deployment timelines and rollout plans.

 

Activities During the Period

 

The Company continued evaluating the First Saguenay Project as part of its downstream phosphate processing strategy. Management continued assessing project timing, financing alternatives and development options in the context of broader economic uncertainties.

 

Project Expenditures and Advancement

 

No material project-specific expenditures were incurred during the period. The project remains in the evaluation and planning stage.

 

Next Steps

 

The development of the project plan remains subject to management’s assessment of broader project development considerations including geopolitical and economic factors. There is currently no timeline for the advancement of the project.

 

The Company’s mineral exploration and development activities, and the construction and operation of the Proposed Downstream Facilities are subject to many conditions and uncertainties including in relation to financing and approvals. Funding and approval discussions for the Proposed Downstream Facilities are ongoing. There is no guarantee that the Company will be successful in obtaining any or all of the requisite funding consents, permits or approvals, regulatory or otherwise, for its proposed mineral exploration, development and extraction, or for either of the Proposed Downstream Facilities. See “Risk Factors”.

 

RESULTS OF OPERATIONS

 

For the three months ended August 31, 2026

 

The following analysis of the Company’s operating results for the three months ended August 31, 2026 includes a comparison against the three months ended August 31, 2025.

 

Revenue:

 

The Company has no active business operations that generate revenue.

 

8

 

Expenses:

 

Mining exploration and metallurgy expenses for the three months ended August 31, 2026 were $7,365,756 compared to $1,463,750 for the three months ended August 31, 2025. The expenses mainly related to its latest drill program at the Bégin-Lamarche Property. For the period, the Company recognized tax credits related to resources for $130,677 (2025 - $329,657) due from the Government of Quebec for qualified exploration expenditures incurred in Quebec. The tax credits have been recognized as a reduction of the related expenses.

 

Professional fees for the three months ended August 31, 2026 were $157,622 compared to $100,480 for the three months ended August 31, 2025. The professional fees are comprised of the following:

 

   For the three months ended August 31, 2026
$
   For the three months ended August 31, 2025
$
 
Legal fees   30,492    10,855 
Accounting fees   44,250    37,900 
Research analysts   (60,803)   — 
Capital markets consultants   34,381    — 
Consulting fee expense   74,518    45,749 
Audit fee   34,784    5,976 
    157,622    100,480 

 

The increase in legal, audit and accounting fees is due to the increase in the level of activities that require engaging the services of the respective professionals. The decrease in research analysts expenses is due to reclassification of these expenses under business development. The increase in other professional fees is due to the increase in the level of market research activities for the period.

 

Business development expenses for the three months ended August 31, 2026 were $2,674,926 compared to $143,083 for the three months ended August 31, 2025. The increase in business development expense is due to the increase in the level of business development activities for the period and is associated with the Company’s listing of American depositors receipts on the Nasdaq Stock Exchange.

 

Salaries and benefits expenses for the three months ended August 31, 2026 were $262,350 compared to $nil for the three months ended August 31, 2025. The increase in salaries and benefits is due to the increase in payroll costs for the period.

 

Research and development expenses for the three months ended August 31, 2026 were $426,438 compared to $nil for the three months ended August 31, 2025. The expense is related to engineering costs and feasibility studies for the period.

 

General administrative expenses for the three months ended August 31, 2026 were $239,345 compared to $77,391 for the three months ended August 31, 2025. The increase in general administrative expense is due to the increase in the level of travel activities, advertising, office, and IT expenses for the period.

 

Regulatory and compliance expenses for the three months ended August 31, 2026 were $602,900 compared to $45,724 for the three months ended August 31, 2025. The increase in regulatory expense is due to expenses related to uplisting to Nasdaq Global Market and increase in the level of financing activities for the period.

 

9

 

Share based compensation for the three months ended August 31, 2026 were $1,116,566 compared to $423,577 for the three months ended August 31, 2025. Share based compensation was recorded for the issuance of stock options and RSUs to directors, officers, employees, and consultants of the Company. The increase in share based compensation expense is due to the increase in the level of activity for the period.

 

Gain on amortization of flow through liability for the three months ended August 31, 2026 were $718,086 compared to $463,181 for the three months ended August 31, 2025. The increase is reflective of the increase in the expenditures incurred on eligible exploration and evaluation activities for the period. Amortization of the flow through liability is based on the proportion of the flow through funds spent on eligible exploration and evaluation expenses.

 

Interest income for the three months ended August 31, 2026 was $150,042 compared to $17,620 for the three months ended August 31, 2025. This interest relates to bank deposits and GICs.

 

Other income

 

Government grant income for the three months ended August 31, 2026 was $494,387 as compared to $nil for the three months ended August 31, 2025. This represents the grants accrued or received from NRCan and other institutions related to feasibility studies.

 

Loss for the period

 

The net loss for the three months ended August 31, 2026 was $11,510,005 as compared to $2,006,009 for the three months ended August 31, 2025. This represents an increase in net loss of $9,503,996 and is due to the items discussed above.

 

For the six months ended August 31, 2026

 

The following analysis of the Company’s operating results for the six months ended August 31, 2026 includes a comparison against the six months ended August 31, 2025.

 

Revenue:

 

The Company has no active business operations that generate revenue.

 

Expenses:

 

Mining exploration and metallurgy expenses for the six months ended August 31, 2026 were $13,571,989 compared to $2,726,356 for the six months ended August 31, 2025. The expenses mainly related to its latest drill program at the Bégin-Lamarche property. During the period, the Company recognized tax credits related to resources for $536,388 (2025 - $329,657) due from the Government of Quebec for the qualified exploration expenditures incurred in Quebec. As at August 31, 2026, the tax credits have been recognized as a reduction of the related expenses.

 

10

 

Professional fees for the six months ended August 31, 2026 were $477,493 compared to $192,200 for the six months ended August 31, 2025. The professional fees are comprised of the following:

 

   For the six months ended August 31, 2026
$
   For the six months ended August 31, 2025
$
 
Legal fees   99,296    26,042 
Accounting fees   80,406    87,600 
Capital markets consultants   123,020    — 
Consulting fee expense   124,045    72,582 
Audit fee   50,726    5,976 
    477,493    192,200 

 

The increase in legal , audit and accounting fees is due to the increase in the level of activities that require engaging the services of the respective professionals. The increase in other professional fees is due to the increase in the level of market research activities for the period.

 

Business development expenses for the six months ended August 31, 2026 were $3,638,511 compared to $274,236 for the six months ended August 31, 2025. The increase in business development expense is due to the increase in the level of business development activities for the period and is associated with the Company’s listing of American depositors receipts on the Nasdaq Stock Exchange.

 

Salaries and benefits expenses for the six months ended August 31, 2026 were $430,542 compared to $nil for the six months ended August 31, 2025. The increase in salaries and benefits is due to the increase in payroll costs for the period.

 

Research and development expenses for the six months ended August 31, 2026 were $891,765 compared to $nil for the six months ended August 31, 2025. The expense is related to engineering costs and feasibility studies for the period.

 

General administrative expenses for the six months ended August 31, 2026 were $682,752 compared to $148,966 for the six months ended August 31, 2025. The increase in general administrative expense is due to the increase in the level of travel activities, advertising, office, and IT expenses for the period.

 

Regulatory and compliance expenses for the six months ended August 31, 2026 were $661,151 compared to $72,468 for the six months ended August 31, 2025. The increase in regulatory expense is due to expenses related to uplisting to Nasdaq Global Market and increase in the level of financing activities for the period.

 

Share based compensation for the six months ended August 31, 2026 were $2,406,412 compared to $864,968 for the six months ended August 31, 2025. Share based compensation was recorded for the issuance of stock options and RSUs to directors, officers, employees, and consultants of the Company. The increase in share based compensation expense is due to the increase in the level of activity for the period.

 

Gain on amortization of flow through liability for the six months ended August 31, 2026 were $862,768 compared to $823,926 for the six months ended August 31, 2025. The increase is reflective of the increase in the expenditures incurred on eligible exploration and evaluation activities for the period. Amortization of the flow through liability is based on the proportion of the flow through funds spent on eligible exploration and evaluation expenses.

 

Interest income for the six months ended August 31, 2026 were $246,948 compared to $30,234 for the six months ended August 31, 2025. This interest relates to bank deposits and GICs.

 

11

 

Other income

 

Government grant income for the six months ended August 31, 2026 was $2,196,511 as compared to $nil for the six months ended August 31, 2025. This represents the grants accrued or received from NRCan and other institutions related to feasibility studies.

 

Loss for the period

 

The net loss for the six months ended August 31, 2026 was $19,504,359 as compared to $3,754,347 for the six months ended August 31, 2025. This represents an increase in net loss of $15,750,012 and is due to the items discussed above.

 

FINANCIAL POSITION

 

As at August 31, 2026, the Company had total assets of $30.8 million, compared with $28.7 million as at February 28, 2026, an increase of $2.1 million. Current assets increased by $2.0 million to $26.8 million, while non-current assets increased by $74,398 to $4.0 million. Total liabilities increased by $1.0 million to $4.9 million, and shareholders’ equity increased by $1.1 million to $25.8 million.

 

  

August 31, 2026

$

  

February 28, 2026

$

  

Change

$

 
Cash and cash equivalents   19,949,271    20,190,457    (241,186)
Restricted cash   90,000    40,000    50,000 
Amounts receivable   54,620    101,042    (46,422)
Tax credits and grants receivable   5,011,536    3,348,184    1,663,352 
Prepaid expenses   1,714,630    1,093,593    621,037 
Total current assets   26,820,057    24,773,276    2,046,781 
Investments   173,790    169,960    3,830 
Exploration and evaluation assets   3,638,061    3,591,734    46,327 
Right-of-use assets   144,381    120,140    24,241 
Total assets   30,776,289    28,655,110    2,121,179 
Accounts payable and accrued liabilities   1,774,867    2,883,651    (1,108,784)
Flow-through share premium liability   2,286,955    182,800    2,104,155 
Lease liabilities   89,475    38,878    50,597 
Total current liabilities   4,151,297    3,105,329    1,045,968 
Lease liabilities   39,926    60,451    (20,525)
Bridge loan   747,246    726,213    21,033 
Total liabilities   4,938,469    3,891,993    1,046,476 
Working capital   22,668,760    21,667,947    1,000,813 
Shareholders' equity   25,837,820    24,763,117    1,074,703 

 

Assets

 

Current assets increased by $2.0 million, primarily due to a $1.7 million increase in tax credits and government grants receivable and a $0.6 million increase in prepaid expenses. The increase in tax credits and grants receivable reflects the recognition of additional refundable mining tax credits and government contributions associated with qualifying exploration, engineering and feasibility activities. The increase in prepaid expenses reflects costs paid in advance for activities to be carried out after August 31, 2026. These increases were partially offset by a $0.2 million decrease in cash and cash equivalents and a $46,422 decrease in amounts receivable.

 

12

 

Non-current assets increased by $74,398 to $4.0 million. Exploration and evaluation assets increased by $46,327 due to new claims staked in the Bluesky areas. The net increase in non-current assets also reflected a $24,241 increase in right-of-use assets and a $3,830 increase in long-term investments.

 

Liabilities

 

Total liabilities increased by $1.0 million. Accounts payable and accrued liabilities decreased by $1,108,784 to $1,774,867, reflecting the settlement and timing of supplier and accrued obligations. This decrease was more than offset by a $2.1 million increase in the flow-through share premium liability arising from flow-through financings completed during the period, net of amortization recognized as eligible expenditures were incurred. Lease liabilities increased by $30,072, while the bridge loan increased by $21,033.

 

Working capital

 

Working capital increased by $1.0 million to $22.7 million from $21.7 million. The improvement primarily reflects the June and July 2026 equity financings and the increase in recognized tax credits and government grants receivable, partially offset by cash used to fund the Company’s exploration, development and corporate activities during the six months ended August 31, 2026.

 

Shareholders' equity

 

Shareholders’ equity increased by $1.1 million to $25.8 million. Capital stock increased by $18.5 million, primarily because of equity financings and warrant and option exercises, and contributed surplus increased by $1.9 million, mainly from share-based compensation and warrant-related amounts. These increases were partially offset by the net loss of $19.5 million for the six months ended August 31, 2026. Shares to be issued increased by $0.2 million.

 

CASH FLOW ANALYSIS

 

For the six months ended August 31, 2026, cash and cash equivalents decreased by $0.2 million to $19.9 million, compared with an increase of $5.7 million to $7.6 million for the six months ended August 31, 2025. The current-period decrease reflects $21.1 million of cash used in operating activities and $46,599 used in investing activities, substantially offset by $20.9 million provided by financing activities.

 

   For the six months ended August 31, 2026
$
   For the six months ended August 31, 2025
$
  

Change

$

 
Operating activities   (21,073,614)   (5,419,317)   (15,654,296)
Investing activities   (46,599)   —    (46,599)
Financing activities   20,879,027    11,136,400    9,742,627 
Net change in cash   (241,186)   5,717,082    (5,958,268)
Cash at end of period   19,949,271    7,590,632    12,358,639 

 

13

 

Operating activities

 

Net cash used in operating activities was $21.1 million for the six months ended August 31, 2026, compared to $5.4 million for the six months ended August 31, 2025. The increase in cash used primarily reflects the higher net loss and expanded exploration, metallurgy, engineering, feasibility, business development and corporate activities during the current period. The net loss of $19.5 million was adjusted for non-cash items, including $2.4 million of share-based compensation, $0.2 million of shares issued for exploration activities, depreciation and interest expense, partially offset by $0.9 million of flow-through share premium amortization and a foreign exchange gain.

 

Changes in non-cash working capital increased cash used in operations. Tax credits and government grants receivable increased by $1.7 million, prepaid expenses increased by $0.6 million, accounts payable and accrued liabilities decreased by $1.1 million, and restricted cash increased by $50,000. These outflows were partially offset by a $46,422 decrease in other receivables.

 

Investing activities

 

Net cash used in investing activities was $46,599 for the six months ended August 31, 2026, compared to $nil for the six months ended August 31, 2025. The current-period amount related to new claims staked in the Bluesky areas and a payment associated with right-of-use assets.

 

Financing activities

 

Net cash provided by financing activities was $20.9 million for the six months ended August 31, 2026, compared to $11.1 million for the six months ended August 31, 2025. Current-period inflows comprised $17.7 million of proceeds from the issuance of units and shares, $3.1 million from warrant exercises and $0.3 million from option exercises, partially offset by $168,881 of share issuance costs and $26,556 of lease liability payments.

 

Relationship between expenditures and project advancement

 

The principal project-related use of cash for the six-month period was the expansion of exploration and metallurgy activities. Expenditures of $12.9 million at the Bégin-Lamarche Property related primarily to drilling activities intended to provide geological and technical information for metallurgical evaluation and the Board’s consideration of the next project stage. Research and development expenditures of $0.9 million related to engineering costs and feasibility studies supporting the Company’s project and downstream development plans. The Company also incurred $0.7 million on prospecting and drilling at the Bluesky areas.

 

SUMMARY OF QUARTERLY RESULTS

 

The following quarterly financial data is derived from the financial statements of the Company as at and for the three-month periods ended on the dates indicated below. The information should be read in conjunction with the Company’s condensed interim consolidated financial statements and the accompanying notes thereto.

 

14

 

   Aug 31/26
$
   May 31/26
$
   Feb 28/26
$
   Nov 30/25
$
 
Total assets   30,776,289    25,851,034    28,655,110    25,126,133 
Working capital   22,668,760    18,402,219    21,667,947    20,100,795 
Shareholders' equity   25,837,820    21,486,048    24,763,117    23,890,844 
Net loss for the 3 months then ended   (11,510,005)   (7,994,354)   (13,910,544)   (5,777,828)
Loss per share   (0.06)   (0.04)   (0.08)   (0.04)

 

   Aug 31/25   May 31/25   Feb 28/25   Nov 30/24 
   $   $   $   $ 
Total assets   14,682,668    8,735,500    7,452,772    5,501,795 
Working capital   10,655,163    4,404,131    2,631,423    976,476 
Shareholders' equity   14,418,439    8,167,351    6,391,331    5,065,493 
Net loss for the 3 months then ended   (2,006,009)   (1,748,338)   (1,539,649)   (1,681,986)
Loss per share   (0.02)   (0.02)   (0.02)   (0.02)

 

LIQUIDITY AND CAPITAL RESOURCES

 

The Company manages the capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. The Company currently does not generate revenue. It has incurred losses and negative cash flows from operations since inception. To maintain or adjust the capital structure, the Company may attempt to issue new shares. The Company intends to raise capital by future financings and non-dilutive options. There is no guarantee that additional financing or non-dilutive options will be available or that it will be available on terms acceptable to management of the Company. The continuing operations of the Company are dependent upon its ability to continue to raise adequate financing. If the Company is not successful in raising sufficient capital, the Company may have to curtail or otherwise limit its operations. See “Risk Factors” of this MD&A.

 

In order to facilitate the management of its capital requirements, the Company prepares expenditure budgets that are updated as necessary depending on various factors, including successful capital deployment and general industry conditions.

 

Management reviews the capital structure on a regular basis to ensure that the above objectives are met. There have been no changes to the Company’s approach to capital management during the period ended August 31, 2026. The Company is not subject to externally imposed capital requirements.

 

As of August 31, 2026, the Company had $19,949,271 in cash and cash equivalents, $90,000 in restricted cash, $5,011,536 of current government receivables and $2,651,514 in financial liabilities. As of the date of this MD&A, the Company had cash and current receivables of $21,832,725. This is comprised of $17,471,461 of cash, $90,000 of restricted cash and $4,271,264 of current government receivables.

 

During the six months ended August 31, 2026, the Company completed equity financings generating aggregate gross proceeds of $17,698,290 and received $3,376,174 from warrant and option exercises. These financings strengthened the Company's working capital position and supported its exploration, development and corporate activities.

 

15

 

Use of Proceeds Assuming No Additional Financing

 

As of the date of this MD&A, the Company intends to use its financial resources for the advancement of the objectives and milestones outlined below over the next 12 months.

 

Category Expense
   
Professional Fees (Audit, Accounting, Legal) $493,000
Public Company Costs $496,900
General and Administration Expenses $2,544,000
Business Development, Public Relations, Conferences $1,800,000
Engineering, Feasibility, Permitting $5,906,890
Exploration & Metallurgical Activities $4,698,200
Total $15,938,990

 

The above noted allocation represents the Company’s intentions with respect to its use of available funds based on current knowledge, planning and expectations of management of the Company. Although the Company intends to expend the proceeds as set forth above, there may be circumstances where, for sound business reasons, a reallocation of funds may be deemed prudent or necessary and may vary materially from that set forth above, as the amounts actually allocated and spent will depend on a number of factors, including the Company’s ability to execute on its business plan and financing objectives. The use of proceeds table above is considered future-oriented financial information. Please see “Cautionary Statement Regarding Forward-Looking Information”.

 

Certain directors receive compensation primarily in securities-based consideration to assist the Company with maintaining sufficient cash flow. By adhering to the planned operating budget as set forth in the table above, the Company projects that it has the financial resources to maintain operations beyond mid 2027. The Company intends to raise capital by future financings and non-dilutive options. There is no guarantee that additional financing or non-dilutive options will be available or that it will be available on terms acceptable to management of the Company.

 

The Company has incurred negative operating cash flow since inception. The Company expects to use the net proceeds from the sale of securities in pursuit of objectives set out in this MD&A. To the extent that the Company has negative operating cash flows in future periods, it may need to deploy a portion of the net proceeds from the sale of securities and/or its existing working capital to fund such negative cash flow. See “Risk Factors”.

 

Update and Comparison of Actual Expenditures to Budget

 

The Company's MD&A for the year ended February 28, 2026 and MD&A for Q1 2027 disclosed a 12-month budget of approximately $21.7 million and $18.7 million, respectively. The following events and circumstances that occurred during the period are considered to be reasonably likely to impact the Company’s budget for the balance of financial year:

 

-Bégin-Lamarche Property: The Company completed drilling on the property and a feasibility study is underway reducing budgeted drilling amounts on the property. Approximately $5.9 million remains estimated for engineering, feasibility, and permitting.

 

-Bluesky Areas: The Company recommenced prospecting and exploration activities of properties outside of the Bégin-Lamarche Property and the Lac à l'Orignal Property. Approximately $4.7 million of previously unallocated funds are now estimated for further exploration.

 

16

 

-In August 2026, the Company’s ADRs were listed on the Nasdaq Global Market. The listing resulted in one-time fees, and increased ongoing regulatory, professional and investor relations costs.

 

-The Company raised an aggregate of $17.7 million in private placement financings, $3.4 million from warrant and option exercises, and CMIF infrastructure contributions equal to the lesser of 50% of total eligible project expenditures and $4,842,937. The additional resources enabled the Company to expedite segments of its business plan resulting in increased expenditures over the period.

 

Category  FYE 2026 12-month budget ($)  Actual – six months ended Aug. 31, 2026 ($)  Over / (under) ($)  % 
Exploration & Metallurgical Activities* 7,317,306  11,575,400 4,258,094  158% 
Professional fees  411,000  477,493  66,493  116% 
Public company costs  202,900  661,151  458,251  326% 
Business Development, Public Relations, Conferences 2,000,000  3,638,511  1,638,511  182% 
General and Administration Expenses 2,256,000  1,113,294  (1,142,706)  49% 
Engineering, Feasibility, Permitting 9,538,688  2,888,354  (6,650,334)  30% 
Total  21,725,894  20,354,203  (1,371,691)  94% 
Less: government grants —  (2,196,511)     
Net expenditures  21,725,894  18,157,692    84% 

*Exploration and metallurgy excludes $1,996,589 of costs incurred related to engineering, feasibility, and permitting, which are presented in mining exploration and metallurgy in the financial statements.

 

In the first six months, the Company spent 94% of its 12-month budget (84% net of grants), mainly due to: 

 

●Exploration & Metallurgical Activities: The Company exceeded this budgeted item by $4.3 million due to expanded Bégin-Lamarche Property drilling and metallurgical testing expenditures, and the previously unbudgeted Bluesky Areas activities, funded by flow-through financings. 

●Regulatory and business development: The combined expenditures for these items exceeded budgeted amounts by $2.1 million. The original budget did not contemplate expenditures incurred in relation to the ADR uplisting to Nasdaq. 

●Engineering, Feasibility and Permitting: These expenditures largely remain budgeted to be expended in the future.

 

17

 

Contractual Obligations

 

The following table summarizes the Company's contractual obligations as at August 31, 2026, on an undiscounted basis:

 

Contractual Obligations  Total $  Less than 1 year $  1–3 years $  4–5 years $ 
Debt – bridge loan (1)  905,459  — — 905,459 
Lease liabilities (2)  129,401  89,475 39,926  —
Purchase obligations – land option fees (3)  352,890  274,299  78,591  —
Flow-through expenditure commitment (4)  11,158,458  11,158,458  — —
Other obligations – accounts payable and accrued liabilities  1,774,867  1,774,867  —  —
Total contractual obligations  14,321,075 13,297,099  118,517  905,459 

(1) The bridge loan is a €450,000 customer prepayment received under an amendment to the offtake letter of intent (LOI). It bears interest at 6% per annum. It is repayable in cash only if the Company does not proceed to production by the time the LOI expires on December 16, 2029. If the Company proceeds to production, the prepayment is recovered through purchase rebates instead of cash. The amount shown is the carrying amount of $747,246 plus interest to December 16, 2029, translated at the August 31, 2026 exchange rate.

 

(2) Lease liabilities cover the office sublease and two vehicle leases. The August 2026 vehicle lease includes the purchase option of about $5,000, which is included in the measurement of that lease liability.

 

(3) Option fees for the Phase 1 Site (298,645 m²) under the agreement with the Saguenay Port Authority, payable quarterly in advance on January 1, April 1, July 1 and October 1. The option remains conditional, unless extended, upon the Company meeting financing and plant feasibility milestones prior to December 31, 2026. If these conditions are not met, the 2027 fees would not be payable. Fees for the Phase 2 Site are payable only if that option is exercised.

 

(4) The Company must spend $11,158,458 of flow-through proceeds on qualifying Canadian exploration expenditures.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

The Company does not utilize off-balance sheet transactions.

 

CAPITAL STOCK

 

The authorized capital stock of the Company is an unlimited number of common shares and an unlimited number of preferred shares issuable in series. As at August 31, 2026, the Company had 190,419,664 common shares outstanding with share capital of $91,282,182 and as at August 31, 2025, the Company had 123,546,512 common shares outstanding with share capital of $42,148,703. As at the date of this MD&A, the Company has 190,419,664 common shares outstanding. There are no preferred shares issued or outstanding.

 

Omnibus Equity Incentive Plan

 

On August 28, 2026, Company shareholders re-approved the Company’s Omnibus Equity Incentive Plan, as amended (the “Omnibus Plan”), for a three-year term ending August 28, 2029. The Omnibus Plan provides the Company with the flexibility to grant diverse equity awards as part of its objective to attract, retain and motivate highly qualified directors, officers, employees and consultants, all granted under one plan and which allows such awards to be subject to the same administration and overall limits.

 

The Omnibus Plan is a “rolling” share-based compensation plan pursuant to which the aggregate number of common shares reserved for issue under the Omnibus Plan may not exceed twenty percent (20%) of the common shares issued and outstanding at the time of option or RSU grant. As at August 31, 2026, the Company had 7,650,000 common shares reserved for issuance pursuant to options grants and 942,500 common shares pursuant to RSU grants. In aggregate, the Company had 8,592,500 common shares reserved for issuance pursuant to options and RSUs granted and outstanding, representing 4.32% of the common shares outstanding on a partially diluted basis.

 

18

 

As of the date of this MD&A, the Company is authorized to issue up to an aggregate of 29,491,433 options and/or RSUs.

 

Restricted Share Units

 

The following details the changes in outstanding RSUs for the six months ended August 31, 2026:

 

  Number of RSUs
Outstanding, February 28, 2025 —
Granted during the period 2,658,580
Vested and exercised during the period (2,658,580)
Outstanding, August 31, 2025 —
Outstanding, February 28, 2026 —
Granted during the period 2,026,134
Cancelled during the period (30,525)
Vested and exercised during the period (991,609)
Outstanding, August 31, 2026 1,004,000

 

As of August 31, 2026, there were 1,004,000 RSUs outstanding.

 

For the six months ended August 31 2026, the Company recorded $1,484,637 of share-based compensation related to the vesting of RSUs (2025 - $771,046).

 

As at the date of this MD&A, the Company has 942,500 RSUs outstanding.

 

Options

 

The following details the changes in outstanding options for the six months ended August 31, 2026:

 

   Number of Options   Weighted Average Exercise Price
$
 
Outstanding, February 28, 2025   8,500,000    0.37 
Issued during the period   —    — 
Expired during the period   (600,000)   0.65 
Outstanding, August 31, 2025   7,900,000    0.35 
           
Outstanding, February 28, 2026   7,650,000    0.72 
Issued during the period   600,000    1.49 
Exercised during the period   (600,000)   0.53 
Outstanding, August 31, 2026   7,650,000    0.79 

 

19

 

The following is a summary of options outstanding and exercisable as of August 31, 2026:

 

Expiry date  Number of options outstanding   Number of options exercisable   Exercise price
$
   Life remaining 
December 29, 2026   150,000    150,000    0.40    0.33 
April 16, 2027   250,000    250,000    0.40    0.63 
July 10, 2027   150,000    150,500    0.40    0.86 
December 29, 2028   1,800,000    1,800,000    0.40    2.33 
December 29, 2028   4,700,000    1,175,000    0.90    2.33 
December 29, 2028   300,000    —    0.98    2.33 
December 29, 2028   300,000    —    2.00    2.33 
    7,650,000    3,525,000           

 

For the six months ended August 31, 2026, the Company recorded $921,775 of share-based compensation related to the vesting of options (2025 - $93,922). The fair value of options issued was determined based on the Black Scholes pricing model, with the following weighted average inputs:

 

Weighted Averages  2026   2025 
Share price  $1.22    — 
Dividend yield   Nil    — 
Exercise price  $1.49    — 
Risk-free interest rate   2.82%   — 
Expected volatility   96.71%   — 
Expected expiration   2.61    — 

 

As at the date of this MD&A, the Company has 7,650,000 options outstanding and of which 3,600,000 options are exercisable.

 

Warrants

 

The following details the changes in outstanding warrants for the six months ended August 31, 2026:

 

   Number of warrants   Weighted Average Exercise Price
$
 
Outstanding, February 28, 2025   17,239,664    0.54 
Issued during the period   3,525,601    0.50 
Outstanding, August 31, 2025   20,765,265    0.53 
           
Outstanding, February 28, 2026   7,243,850    0.94 
Issued during the period   2,026,475    2.50 
Expired during the period   (2,169,911)   1.25 
Exercised during the period   (2,448,939)   1.25 
Outstanding, August 31, 2026   4,651,475    1.31 

 

20

 

The following is a summary of warrants outstanding as at August 31, 2026:

 

Expiry date  Number of warrants outstanding   Number of warrants exercisable   Exercise price
$
   Weighted average life remaining 
December 31, 2026   2,026,475    2,026,475    2.50    0.33 
December 30, 2028   2,625,000    2,625,000    0.40    2.33 
    4,651,475    4,651,475           

 

As at the date of this MD&A, the Company has 4,651,475 warrants outstanding.

 

RELATED PARTY TRANSACTIONS

 

Related parties and related party transactions impacting the accompanying financial statements are summarized below and include transactions with the following individuals or entities:

 

Key management personnel

 

Key management personnel include those persons having authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The Company has determined that key management personnel consist of executive and non-executive members of the Company’s Board and corporate officers. They are listed below:

 

Related party Relationship  
John Passalacqua Chief Executive Officer (“CEO”) and Director  
Laurence W. Zeifman Chairman and Independent Director  
Bennett Kurtz

Chief Administrative Officer (“CAO”), Chief Financial Officer (“CFO”), Corporate Secretary, and Director

 
Peter Nicholson Independent Director  
Peter Kent Independent Director  
     

 

Remuneration attributed to key management personnel can be summarized as follows:

 

   For the three months ended August 31   For the six months ended August 31 
  

2026

$

  

2025

$

  

2026

$

  

2025

$

 
Share based compensation   722,137    198,820    1,533,069    436,376 
Management fees   45,500    —    71,000    — 
Financing fees   —    232,804    —    332,578 
    767,637    431,624    1,604,069    768,954 


There are no amounts owed to related parties as of August 31, 2026.

 

Director and Management Services Agreements

 

The Company has director, management service or employment agreements with each of its directors and officers. Under each agreement, the consultant is issued a fixed amount of RSU’s, a combination of cash and RSUs, or salary.

 

21

 

For the six months ended August 31, 2026, ExpoWorld Ltd. (with John Passalacqua as principal) received $832,253 (2025 - $185,511) in share based compensation comprised of options and RSUs. Mr. Passalacqua is the CEO and a director.

 

For the six months ended August 31, 2026, POF Capital Corp. (with Bennett Kurtz as principal) received $254,362 in fees comprised of $71,000 for management services (August 31, 2025 - $nil) in their capacity as a CAO, and $183,362 (2025 - $103,490) share based compensation comprised of options and RSUs. Mr. Kurtz is a director, and serves as the CAO, CFO, Corporate Secretary of the Company.

 

For the six months ended August 31, 2026, Z Six Financial Corporation (with Laurence W. Zeifman and his spouse as the shareholders) received $252,477 in share based compensation (2025 - $71,169) comprised of options and RSUs. Mr. Zeifman serves as Chairman, independent director, Chair of the Audit Committee and as a member of the Compensation Committee of the Company.

 

For the six months ended August 31, 2026, Peter Nicholson and WPCD Inc. received $203,382 in share based compensation (2025 - $49,715) comprised of options and RSUs. Mr. Nicholson serves as independent director, Chair of the Compensation Committee and as a member of the Audit Committee of the Company.

 

For the six months ended August 31, 2026, Peter Kent Investments (with Peter Kent as principal) received $61,595 in share based compensation (2025 - $nil) comprised of options and RSUs. Mr. Kent serves as independent director, and as a member of the Audit Committee of the Company.

 

CRITICAL ACCOUNTING ESTIMATES

 

The preparation of financial statements requires management to make estimates and assumptions. The Company's critical accounting judgements and key sources of estimation uncertainty are described in note 3(c) of the annual financial statements for the year ended February 28, 2026 and were applied in the interim financial statements (note 4). The estimates discussed below are those that require assumptions about highly uncertain matters and where reasonably possible changes could materially affect the Company's financial position or performance. The Company has one reportable segment, so this discussion applies to the Company as a whole.

 

Impairment of exploration and evaluation assets

 

Exploration and evaluation assets of $3,638,061 are assessed for impairment at least annually and whenever facts and circumstances suggest that the carrying amount may exceed the recoverable amount, being the higher of fair value less costs to sell and value in use. The assessment depends on assumptions about whether exploration rights remain in good standing, whether substantive exploration is planned, exploration results and the availability of financing. These are highly uncertain because no property has yet established mineral reserves.

 

Government grants and tax credits recoverable

 

At August 31, 2026, tax credits/grants receivable totalled $5,011,536, including mining tax credits of $2,336,013 and government grants of $1,463,356, and the Company recognized $2,196,511 of government grant income in the six months. Mining tax credits are recognized as a reduction of exploration costs, and grants as income, when there is reasonable assurance that the Company will comply with the related conditions and that the amounts will be received. Management estimates which expenditures are eligible under each program and under Quebec tax legislation, and claims remain subject to review by the funding agencies and Revenu Québec.

 

22

 

Grant income is expected to increase as eligible spending grows under the NRCan agreement (to March 31, 2028) and the First and Last Mile Fund agreements (to March 31, 2029 and March 31, 2030). The $14,272,458 still available under the NRCan agreement has not been accrued.

 

Valuation of share-based payments

 

Share-based compensation was $2,406,412 in the six months ended August 31, 2026. Options and finders' warrants are valued using the Black-Scholes option pricing model, which requires subjective assumptions, principally expected volatility, expected life, and forfeiture rate. RSUs are measured at the closing share price on the grant date, net of estimated forfeitures. Volatility is based on the Company's historical share price, which has been volatile.

 

Changes in estimates and other areas

 

There were no changes in the methodology or key assumptions for the Company's critical accounting estimates in fiscal 2025, fiscal 2026, or the six months ended August 31, 2026. In fiscal 2026, the remaining $332,578 of prepaid financing expense was expensed when the related credit facility expired unused on December 29, 2025, with no effect on total financing expense for the year. A material uncertainty related to going concern was disclosed at February 28, 2025; following equity financings, the Company concluded at February 28, 2026 and August 31, 2026 that it had adequate financing for the next twelve months. The presentation of government grants on a gross basis from March 1, 2026 is a change in accounting policy, not an estimate.

 

Income taxes, lease liabilities, the bridge loan, the investment in IPL, shares issued for non-cash consideration and going concern are not considered critical accounting estimates because the amounts are not material or the matters involve judgement rather than estimation.

 

FINANCIAL INSTRUMENTS

 

Financial instruments are agreements between two parties that result in promises to pay or receive cash or equity instruments. The Company classifies its financial instruments as follows: cash and investments at FVTPL and restricted cash and accounts payable at amortized cost. The carrying values of these instruments approximate their fair values due to their short term to maturity.

 

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of fair value hierarchy are:

 

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities;

Level 2 – Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and

Level 3 – Inputs that are not based on observable market data.

 

23

 

The following table sets forth the Company’s financial assets measured at fair value by levels within the fair value hierarchy:

 

   As at August 31, 2026 
  

Level 1

$

    Level 2
$
 

Level 3

$

   Total
$
 
Cash and cash equivalents   19,949,271             19,949,271 
Long-term investments            173,790    173,790 

 

The investments in Level 3 include the investment in privately held companies that are not quoted on an exchange. Management believes that the price of the shares in the investee’s most recent private placement approximates the fair value.

 

The Company is exposed in varying degrees to a variety of financial instrument related risks:

 

Credit risk 

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company is exposed to a significant credit risk as its maximum exposure relates to cash and restricted cash totaling $20,039,271. The Company mitigates the credit risk of cash by depositing with only reputable financial institutions. The Company also assesses the credit quality of counterparties, taking into account their financial position, past experience and other factors.

 

Liquidity risk 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due.

 

The Company as at August 31, 2026, has $19,949,271 in cash and cash equivalents and $90,000 in restricted cash and $2,651,514 in financial liabilities, consisting of $1,774,867 in accounts payable and accrued liabilities, $129,401 in lease liabilities, and $747,246 in bridge loans, which represents the Company's maximum exposure to liquidity risk.

 

The following table summarizes the Company’s financial liabilities as at August 31, 2026:

 

Financial liabilities 

Due ≤ 1 year

$

  

Due 1–5 years

$

  

Total carrying amount

$

 
Accounts payable and accrued liabilities   1,774,867    —    1,774,867 
Lease liabilities   89,475    39,926    129,401 
Bridge loan   —    747,246    747,246 
Total   1,864,342    787,172    2,651,514 

 

The above table presents undiscounted contractual cash flows; totals therefore exceed carrying amounts by the related future interest. The bridge loan is repayable in cash, together with simple interest at 6% per annum, only if the Company does not proceed to positive production Decision. As of August 31, 2026, the Company has sufficient working capital to satisfy its financial liabilities.

 

24

 

Market risk

 

Market risk is the risk of loss that may arise from changes in market factors such as interest rates, foreign exchange rates, and equity prices. The Company is not exposed to material market risk.

 

a)Interest rate risk

 

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.

 

The risk that the Company will realize a loss as a result of a change in the interest rate is low, as the Company has no investments or liabilities with variable interest rates.

 

b)Foreign currency risk

 

Foreign currency risk is the risk that the fair value of future cash flows of the Company’s financial instruments will fluctuate as a result of changes in foreign exchange rates. As of August 31, 2026, a portion of the Company’s financial assets, comprising long-term investments, are held in Great British Pound (“GBP”). A 1% change in the exchange rate would result in a change of net loss or gain by $1,738 In addition, a portion of the Company’s financial liabilities, comprising bridge loans, are held in Euro (“EUR”). 1% change in the exchange rate would result in a change of net loss or gain by $7,472 The impact of fluctuations in foreign exchange rates is not significant and, accordingly, a sensitivity analysis has not been provided.

 

c)Price risk

 

Price risk is related to equity and commodity price risks. Equity price risk is defined as the potential adverse impact on the Company’s earnings due to movements in individual equity prices or general movements in the level of the stock market. Commodity price risk is defined as the potential adverse impact on earnings and economic value due to commodity price movements and volatilities. As the Company holds no significant equity or commodity related investments or assets, the Company has minimal exposure to price risk.

 

DISCLOSURE CONTROLS AND PROCEDURES AND INTERNAL CONTROL OVER FINANCIAL REPORTING

 

On August 10, 2026, the Company's American Depositary Receipts began trading on the Nasdaq Global Market. As a result, the Company became a "non-venture issuer" as defined in National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings ("NI 52-109").

 

As permitted by section 5.5 of NI 52-109 for the first interim period ending after an issuer becomes a non-venture issuer, the Company's Chief Executive Officer and Chief Financial Officer (the "Certifying Officers") have filed interim certificates in Form 52-109F2 – IPO/RTO for the interim period ended August 31, 2026. These certificates do not include representations on the design of disclosure controls and procedures ("DC&P") and internal control over financial reporting ("ICFR"). In particular, the Certifying Officers do not make any representations relating to the establishment and maintenance of: controls and other procedures designed to provide reasonable assurance that information required to be disclosed by the Company in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS.

 

25

 

The Certifying Officers are responsible for ensuring that processes are in place to give them sufficient knowledge to support the representations in their certificates. Investors should be aware that inherent limitations on the Certifying Officers' ability to design and implement DC&P and ICFR on a cost-effective basis may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation.

 

Management is designing DC&P and ICFR to meet the requirements that apply to non-venture issuers, using the Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Beginning with the interim period ending November 30, 2026, the Certifying Officers expect to certify the design of DC&P and ICFR in Form 52-109F2. For the year ending February 28, 2027, they expect to certify both the design and the operating effectiveness of DC&P and ICFR in Form 52-109F1.

 

RISK FACTORS

 

The Company’s risk factors are substantially unchanged from and should be read in conjunction with the Company’s MD&A for the year ended February 28, 2026. These risk factors are those that the Company currently believes to be material, but they are not the only ones it faces. If any of the risks identified by the Company, or any other risks and uncertainties that the Company has not yet identified or that it currently considers not to be material, actually occur or become material risks, the Company’s business, financial condition and operating results may be materially adversely affected. In that event, the trading price of our securities could be materially and adversely affected.

 

FORWARD LOOKING STATEMENTS

 

This MD&A contains forward-looking statements and information within the meaning of applicable securities legislation (collectively, "forward-looking statements"). These forward-looking statements relate to, among other things, the objectives, goals, strategies, beliefs, intentions, plans, estimates and outlook of the Company.

 

Forward-looking statements can generally be identified by the use of words such as "believe", "anticipate", "expect", "continue", "intend", "aim", "plan", "budget", "goal", "estimate", "forecast", "foresee", "close to", "target", "potential" or negative versions thereof and similar expressions, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Forward looking statements are based on estimates and assumptions made by the Company in light of its experience and perception of historical trends, current conditions and expected future developments, as well as other factors the Company believes are appropriate in the circumstances. Any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking statements. Statements containing forward-looking statements are not historical facts but instead represent management's expectations, estimates and projections regarding future events or circumstances and are subject to change. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, undue reliance should not be placed on such statements.

 

26

 

The forward-looking statements in this MD&A include, among other things, statements relating to the Company's business objectives and milestones; statements concerning the Company's plans at the Properties; requirements for and availability of additional capital; the Company's business plans and strategies; the Company's expectations regarding the Company's future results, including, among others, revenue, expenses, expenditures, operations, and use of future cash flow; expectations regarding the potential mineralization, geological merit and economic feasibility of the Company’s projects; mineral exploration and exploration program cost estimates; expectations regarding any environmental issues that may affect planned or future exploration programs and the potential impact of complying with existing and proposed environmental laws and regulations; receipt and timing of exploration and exploitation permits and other third-party approvals; government regulation of mineral exploration and development operations; expectations regarding any social or local community issues that may affect planned or future exploration and development programs; expectations surrounding global economic trends and technological advancements; and key personnel continuing their employment with the Company.

 

The forward-looking statements in this MD&A also include future budgets for the Company and its business which may be considered future oriented financial information or financial outlooks within the meaning of applicable Canadian securities legislation (collectively, “FOFI”). It has been approved by management of the Company and is based on assumptions which management believes were reasonable on the date such FOFI was prepared, having regard to the industry, business, financial conditions, plans and prospects of the Company and its business and properties, assuming, among other things, no additional financing, engineering, feasibility and permitting costs are presented net of expected government contributions, and excludes non-cash items and no additional funding allocated to the First Saguenay Project. These projections are provided to describe the prospective performance of the Company's business. Nevertheless, readers are cautioned that such information is highly subjective and should not be relied on as necessarily indicative of future results and that actual results may differ significantly from such projections. FOFI constitutes forward-looking statements and is subject to the same additional assumptions, uncertainties, risk factors and qualifications as set forth herein.

 

In making the forward-looking statements in this MD&A, the Company has made several assumptions, including, but not limited to, assumptions concerning: the accuracy of geological interpretation and statistical inferences or assumptions drawn from drilling and sampling analysis and metallurgical testing that are involved in the calculation of mineral reserves and mineral resources; that engineering and construction timetables and capital costs for the Company's development and expansion projects are correctly estimated not affected by unforeseen circumstances; that the Company is able to obtain financing for its proposed operations on reasonable terms; that there is no material deterioration in general business and economic conditions; no material delays in obtaining permits and other approvals; there being no significant disruptions affecting the activities of the Company or its ability to access required project equipment and services, and operating supplies in sufficient quantities and on a timely basis; inflation and prices for Company project inputs being approximately consistent with anticipated levels; the Company’s ability to complete its exploration and development programs consistent with its expectations; commodity price expectations including assumptions for P205; the Company’s relationship with First Nations and other Indigenous parties remaining consistent with the Company’s expectations; the Company’s relationship with other third party partners and suppliers remaining consistent with the Company’s expectations; and government relations and actions being consistent with Company expectations.

 

27

 

Actual results may differ materially from those expressed or implied in the forward-looking statements contained in this AIF. The Company anticipates that subsequent events and developments may cause the Company's views to change. Factors which could cause results or events to differ from current expectations include, among other things: Limited Operating History; the Company’s Size and Resources; Negative Cash Flow and Dependence on Additional Financing; Mineral Exploration and Development; Mineral Resources and Reserve Estimates; Capital Requirements for Development; Title; Indigenous Title and Land Claims; Infrastructure; Mining and Processing Operations; the Development and Operation of Processing and Manufacturing Facilities; Third Party Suppliers; Production of Battery-Grade Precursor Materials; the Availability of Supplies and Equipment; Dependence on Outside Parties; Permits, Licenses, Approvals and Regulatory Compliance; Reputation; Land Reclamation; Health and Safety; Insurance Coverage; Changes in Battery Technology; Commodity Prices and Revenue Fluctuations; Competition in Precursor Materials Markets; Intellectual Property and Processing Technology; Non-Canadian Investors; Foreign Private Issuer Status; Share Price Volatility; Dilution and the Future Sale of Securities; Dividends; Geopolitical Uncertainty; Global Financial Conditions; Uncertain Trade Policies; Key Personnel; Personnel Recruitment and other factors not currently viewed as material that could cause actual results to differ materially from those described in the forward-looking statements. If any of these risks or uncertainties materialize, or if the opinions, estimates, or assumptions underlying the forward-looking statements prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking statements. When relying on forward-looking statements to make decisions with respect to the Company, carefully consider these risk factors and other uncertainties and potential events. Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those factors are described in the Company’s other filings with Canadian and United States securities authorities, all of which are available on SEDAR+ at www.sedarplus.com.

 

Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other risk factors not presently known to the Company or that it does not presently believe are material that could also cause actual results or future events to differ materially from those expressed in such forward-looking statements. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking statements, which speak only as of the date made. The forward-looking statements contained in this AIF represent the Company's expectations as of the date of this MD&A (or as the date they are otherwise stated to be made) and are subject to change after such date. The Company undertakes no obligation to update or revise any forward-looking statement, except as required by law.

 

Information set forth in this MD&A may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as "anticipate", "believe", "plan", "estimate", "expect", and "intend", statements that an action or event "may", "might", "could", "should", or "will" be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein are forward-looking statements. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: the need for additional financing; reliance on key personnel; the potential for conflicts of interest among certain officers, directors, or promoters with certain other projects; the absence of dividends; competition; dilution; the volatility of our common share price and volume and the additional risks identified in the “Risk Factors” section of this MD&A or other reports and filings with applicable Canadian and United States securities regulators.

 

28

 

Forward-looking information and statements included throughout this MD&A are based on a number of factors and assumptions which have been used to develop such statements and information, but which may prove to be incorrect, including, but not limited to, assumptions about the geological interpretation and statistical inferences or assumptions drawn from drilling and sampling analysis that are involved in the calculation of mineral reserves and mineral resources; expectations regarding industry trends, overall market growth rates and the Company's growth rates and growth strategies; that there is no material deterioration in general business and economic conditions; that there is no unanticipated fluctuation of interest rates and foreign currency exchange rates; that the supply and demand for, deliveries of, and the level and volatility of prices of precious and base metals; that the Company receives regulatory and governmental approvals for its development projects and other operations on a timely basis; feasibility of mine and plant development; the Company's business plans and strategies; expenditure and financing requirements; that the Company is able to obtain financing for its development projects on reasonable terms; the Company's ability to execute on its strategic growth priorities and to successfully integrate acquisition targets; that the Company is able to procure exploration equipment and services, and operating supplies in sufficient quantities and on a timely basis; that engineering and construction timetables and capital costs for the Company's development and expansion projects are not incorrectly estimated or affected by unforeseen circumstances; exploration and development risks, that unforeseen changes to the political stability or government regulation in the country in which the Company operates do not occur; the Company's ability to retain key personnel; and that the Company maintains its ongoing relations with its employees, affected communities, business partners and joint venturers.

 

Forward-looking statements are made based on management's beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company does not intend, and does not assume any obligation, to update or revise these forward-looking statements, except as required pursuant to applicable securities laws.

 

29

Exhibit 99.3

 

Form 52-109F2 – IPO/RTO
CERTIFICATION OF INTERIM FILINGS FOLLOWING
AN INITIAL PUBLIC OFFERING, REVERSE TAKEOVER OR
BECOMING A NON-VENTURE ISSUER

 

I, John Passalacqua, Chief Executive Officer of First Phosphate Corp., certify the following:

 

1.Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of First Phosphate Corp. (the "issuer") for the interim period ended August 31, 2026.

 

2.No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

3.Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

 

Date: October 22, 2026

 

/s/“John Passalacqua”

John Passalacqua

Chief Executive Officer

 

NOTE TO READER

In contrast to the usual certificate required for non-venture issuers under National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings (NI 52-109), namely, Form 52-109F2, this Form 52-109F2 – IPO/RTO does not include representations relating to the establishment and maintenance of disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as defined in NI 52-109. In particular, the certifying officers filing this certificate are not making any representations relating to the establishment and maintenance of

i)              controls and other procedures designed to provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

ii)             a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.

 

 

 

 

 

The issuer's certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the representations they are making in this certificate.

Investors should be aware that inherent limitations on the ability of certifying officers of an issuer to design and implement on a cost effective basis DC&P and ICFR as defined in NI 52-109 in the first financial period following

•             completion of the issuer's initial public offering in the circumstances described in s. 5.3 of NI 52-109;

•             completion of a reverse takeover in the circumstances described in s. 5.4 of NI 52-109; or

•             the issuer becoming a non-venture issuer in the circumstances described in s. 5.5 of NI 52-109;

may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation.

 

Exhibit 99.4

 

Form 52-109F2 – IPO/RTO
CERTIFICATION OF INTERIM FILINGS FOLLOWING
AN INITIAL PUBLIC OFFERING, REVERSE TAKEOVER OR
BECOMING A NON-VENTURE ISSUER

 

I, Bennett Kurtz, Chief Financial Officer of First Phosphate Corp., certify the following:

 

1.Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of First Phosphate Corp. (the "issuer") for the interim period ended August 31, 2026.

 

2.No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

3.Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

 

Date: October 22, 2026

 

/s/“Bennett Kurtz”

Bennett Kurtz

Chief Financial Officer

 

NOTE TO READER

In contrast to the usual certificate required for non-venture issuers under National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings (NI 52-109), namely, Form 52-109F2, this Form 52-109F2 – IPO/RTO does not include representations relating to the establishment and maintenance of disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as defined in NI 52-109. In particular, the certifying officers filing this certificate are not making any representations relating to the establishment and maintenance of

i)              controls and other procedures designed to provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

ii)             a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.

 

 

 

 

The issuer's certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the representations they are making in this certificate.

Investors should be aware that inherent limitations on the ability of certifying officers of an issuer to design and implement on a cost effective basis DC&P and ICFR as defined in NI 52-109 in the first financial period following

•             completion of the issuer's initial public offering in the circumstances described in s. 5.3 of NI 52-109;

•             completion of a reverse takeover in the circumstances described in s. 5.4 of NI 52-109; or

•             the issuer becoming a non-venture issuer in the circumstances described in s. 5.5 of NI 52-109;

may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation.

 

 

Filing Exhibits & Attachments

9 documents

Keep reading